The Effects of Resveratrol on Oxidative Stress and Muscle Atrophy by Jackson, Janna Renee
Graduate Theses, Dissertations, and Problem Reports 
2010 
The Effects of Resveratrol on Oxidative Stress and Muscle 
Atrophy 
Janna Renee Jackson 
West Virginia University 
Follow this and additional works at: https://researchrepository.wvu.edu/etd 
Recommended Citation 
Jackson, Janna Renee, "The Effects of Resveratrol on Oxidative Stress and Muscle Atrophy" (2010). 
Graduate Theses, Dissertations, and Problem Reports. 3200. 
https://researchrepository.wvu.edu/etd/3200 
This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research 
Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is 
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain 
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license 
in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, 
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. 
For more information, please contact researchrepository@mail.wvu.edu. 
 
 
The Effects of Resveratrol on Oxidative Stress and Muscle Atrophy 
 
 









Dissertation Submitted to the School of Medicine at West Virginia University 
In Partial Fulfillment of the Requirements for the Degree of 
 
 
Doctor of Philosophy in Physiology  
 
 
Stephen E. Alway, Ph.D., Chair, Mentor 
Robert G. Cutlip, Ph.D. 
Stan M. Hileman, Ph.D. 
John M. Hollander, Ph.D. 
William T. Stauber, Ph.D. 
 
 
Graduate Program in Cellular & Integrative Physiology 









The Effects of Resveratrol on Oxidative Stress and Muscle Atrophy 
Janna Renee Jackson 
 
Increases in oxidative stress and apoptosis are associated with skeletal muscle atrophy 
caused by  prolonged periods o f muscle disuse and also as  p art o f the normal ag ing 
process. The loss of muscle size and strength with age is known as sarcopenia and has 
detrimental implications to the quality of life for elderly individuals. Although the causes 
of sarcopenia and disuse-mediated atrophy are largely unknown, an increased oxidant 
load has the potential to negatively impact both muscle mass and function by directly 
causing oxidative damage to tissue constituents and also via the initiation of the intrinsic 
mitochondrial apop totic pat hway. Due t o i ts m ulti-nucleated cellular s tructure, s keletal 
muscle is an exception with regard to the linear relationship between apoptosis and cell 
death. Apoptosis in skeletal muscle results in the potential loss of both myonuclei and/or 
muscle precursor cells ( i.e. satellite cells). This i s o f particular s ignificance i n skeletal 
muscle g iven that skeletal muscle i s a pos t-mitotic t issue and thus i t’s only means of 
regeneration r ests w ith its a bility t o ac tivate an d pr opagate s atellite c ells. T herefore, 
oxidative stress may potentially contribute to the process of muscle atrophy via a dual -
fold m echanism, by both di rectly ox idizing t he nuc leic ac ids, l ipids and pr oteins t hat 
make u p t he muscle t issue and by  creating a m ore f avorable ap optotic environment 
leading to an eventual loss of myonuclei. 
Resveratrol (3,5,4,trihydroxystilbene) i s a n aturally occurring polyphenol found in over 
seventy plant species that has been shown to have anti-oxidant, anti-apoptotic and anti-
aging pr operties. R esveratrols’ capacity t o en hance t he e ndogenous a nti-oxidant 
system, upr egulate ant i-apoptotic pr oteins and i mprove m itochondrial function, 
presumably t hrough the activation o f t he N AD+ dependent d eacetylase S irtuin1, 
suggests that supplementation with resveratrol may potentially protect skeletal muscle 
from t he d etrimental ef fects of  increases i n oxidative s tress and t he s ubsequent 
increase in apoptotic signaling that are present in many atrophic conditions. Therefore, 
the major g oals o f this di ssertation ar e t o further u nderstand t he i nterplay bet ween 
oxidative stress and skeletal muscle atrophy and to evaluate the efficacy of resveratrol 
as a counter measure to both mitochondrial-induced oxidative stress and apoptosis. 
The first s tudy used hindlimb suspension (HLS) as  a m odel o f disuse at rophy as  i t i s 
known to el icit muscle atrophy, oxidative stress and apoptosis in skeletal muscle. The 
aim o f t he investigation was to analyze the capacity o f resveratrol administration at a  
moderate dose o f 12.5mg/kg/day for 21 days to at tenuate ox idative s tress, apoptosis 
and muscle f orce l oss f ollowing 14  days of  H LS i n y oung and aged r ats. T he s tudy 
yielded m ixed r esults. Resveratrol administration effectively r educed oxidative s tress 
and s ubsequently oxidative dam age in m uscles f rom ag ed a nimals. F urthermore, 
resveratrol adm inistration at tenuated t he r elative l oss of  m uscle mass as  a r atio o f 
animal body  w eight i n g astrocnemius muscles f rom ag ed ani mals; how ever, des pite 
reductions in apoptotic signaling in aged muscles, resveratrol administration was unable 
to mitigate a poptosis as  measured by D NA fragmentation. M oreover, r esveratrol 
administration had no protective effect on gastrocnemius muscles from young animals 
with regard to oxidative or apoptotic indices. Based on these results resveratrol has the 
potential t o b e a n e ffective therapeutic agent t o t reat m uscle functional d ecrements 
associated w ith di suse i n aged i ndividuals, v ia improving t he redox s tatus associated 
with these conditions. 
The second hal f o f the dissertation f ocuses on the c apacity o f l ong-term dietary 
supplementation with resveratrol to protect against aging-induced oxidative stress and 
to enhance mitochondrial signaling, and t hus stem t he pr ogression o f s arcopenia i n 
aged skeletal m uscle. In t his s tudy m iddle-aged ( 18mo) C57BL/6 m ice were 
supplemented w ith a diet c ontaining . 05% trans-resveratrol f or 1 0 m onths until they 
reached senescence (28mo). Gastrocnemius, pl antaris an d v astus l ateralis muscles 
from s upplemented animals w ere c ompared for an ti-oxidant enzyme content and 
activities, oxidant load, oxidative damage, mitochondrial integrity and mass, as well as 
muscle function indices with muscles from young and middle-aged animals receiving a 
control di et. Resveratrol specifically upr egulated t he c apacity o f the m itochondrial 
isoform of s uperoxide di smutase ( MnSOD) and c oncomitantly dec reased hy drogen 
peroxide concentrations. This was paralleled by reductions in lipid peroxidation, but not 
protein oxidation in muscles from supplemented animals. Despite reductions in oxidant 
load and lipid peroxidation resveratrol, supplementation was unable to confer protection 
against s arcopenia. Furthermore, plantaris m uscles from s upplemented ag ed animals 
did not show enhanced resistance to muscle fatigue, nor an increase in maximal force 
production. 
Taken as a whole these results suggest that resveratrol may be most effective when 
used as a pharmacological pre-conditioner to help confer resistance to oxidative 
damage under perturbations that are known to increase oxidative stress. Specifically, 
resveratrol may be an effective therapeutic agent to improve the redox status of aged 
skeletal muscle and therefore allow for improved adaptation and recovery following 
chronic illness and/or injuries during which the capacity of the endogenous antioxidant 
system may be overwhelmed in aged individuals. Gaining clearer insight into the 
molecular signaling pathways involved in aging and disuse muscle atrophy is 
paramount in developing nutritional and/or pharmacological interventions to minimize 
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With advanced age there is a progressive loss of skeletal muscle mass, termed 
sarcopenia (32). The frailty and loss of function associated with sarcopenia puts the 
elderly at an increased risk of falls and subsequent injury, resulting in a marked 
decrease of their quality of life (6; 17). Furthermore, sarcopenia represents a 
tremendous financial burden; the estimated direct healthcare costs attributable to 
sarcopenia in the United States in the year 2000 was $18.5 billion (18). The causative 
factors of sarcopenia are multi-factorial and include a progressive denervation of muscle 
fibers (11), an altered hormonal milieu (35), and an increase in protein degradation and 
a concomitant decrease in protein synthesis, resulting in a net loss of contractile 
proteins (19; 29). Moreover, sarcopenia can be compounded by reductions in dietary 
intake (31) and activity levels (10) often associated with advanced age.  
Both advanced age and disuse are associated with atrophy and an increased 
production of reactive oxygen species (ROS) in skeletal muscle (24; 25; 28), leading to 
an augmented oxidant-load.  When an increase in pro-oxidant production exceeds an 
organisms’ capacity to buffer them, via a complex coordination of the endogenous 
antioxidant defense system, oxidative stress occurs. Oxidative stress, left unchecked 
over time leads to the oxidation, and thus damage, of cellular macromolecules, 
including lipids (26), nucleic acids (15) and proteins (2; 9; 16). The progressive oxidative 
assault on cellular organelles is believed to be a main contributor to the aging process 
(13) and is thought to be responsible for many of the pathologies associated with aging, 




Oxidative stress is believed to be a common underlying mechanism potentiating 
many of the factors leading to muscle loss with aging (12; 28), of particular interest is 
the redox sensitive apoptotic pathway (37). Oxidative stress is upstream of apoptotic 
signaling in muscle cells (34) and results in the initiation of the intrinsic mitochondrial 
apoptotic pathway.  Due to its multi-nucleated cellular structure, skeletal muscle is an 
exception with regard to the linear relationship between programmed cell death and 
apoptotic signaling. Instead, apoptosis in skeletal muscle results in a loss of myonuclei 
and consequent fiber atrophy (1). 
Antioxidant supplementation has been shown to be an effective counter measure 
to combat oxidative stress in a wide variety of tissue types and conditions (7; 28) and it 
is speculated that this might be an approach to reduce muscle wasting associated with 
disuse (33) and aging (7). Dietary supplementation with the polyphenol, resveratrol, 
exerts beneficial effects not only through its’ ability to directly scavenge free radicals (3; 
5), but also by its’ capacity to modulate the signal transduction and gene expression of 
several pathways regulating cellular proliferation (30), mitochondrial biogenesis (20; 36), 
metabolism (12; 13; 28), and survival. The efficacy of acute resveratrol administration 
has been established for several pathological conditions (4; 20; 27); however, the use of 
chronic resveratrol supplementation as a counter-measure to combat oxidative stress-
induced muscle loss and sarcopenia has not been established.  
The long-term goal of this study is to characterize the mechanisms responsible for the 
progression and pathogenesis of sarcopenia and disuse-induced muscle loss and to 
use this information to develop strategies for the prevention and treatment of muscle 
loss with aging. The main objectives of the project were: (1) to characterize the 
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endogenous antioxidant defense system in young and old skeletal muscles exposed to 
hindlimb suspension (HLS); (2) to determine the ability of resveratrol to reduce oxidative 
stress associated with both aging and skeletal muscle disuse via an enhancement of 
the endogenous antioxidant defense system; (3) to evaluate the potential of long-term 
resveratrol supplementation to attenuate the detrimental effects of aging in skeletal 
muscle via reductions in pro-oxidant production by enhancing cellular mitochondrial 
content, integrity and function; (4) to characterize the relationship between oxidative 
stress and myonuclear apoptosis contributing to skeletal muscle atrophy. 
The central hypothesis of the project is that enhancing the muscle’s endogenous 
antioxidant defense system and promoting mitochondrial biogenesis will reduce 
oxidative stress, consequently reducing muscle cell apoptosis. Attenuation of 
myonuclear apoptosis will result in a reduction of skeletal muscle atrophy associated 
with both disuse and advanced age. Our central hypothesis is based on data from our 
laboratory and published data from other laboratories, suggesting that sarcopenia and 
muscle atrophy occurs concurrently with a reduction in mitochondria content and 
increases oxidative stress (12; 22; 23). Resveratrol may act to both reduce oxidative 
stress and improve mitochondria biogenesis (4; 8; 20; 21). The rationale for this project 
is that a delineation of the potential importance of resveratrol to reduce oxidative stress 
and mitochondrial dysfunction potentially leading to attenuation of apoptosis and the 
improved regulation of muscle mass during aging would potentially provide 





Specific Aim 1:  To evaluate the efficacy of resveratrol administration to 
ameliorate muscle atrophy associated with muscle disuse by reducing oxidative 
stress and apoptotic signaling.  
To address aim 1, indices of oxidative stress and the content of mitochondria-
associated apoptotic proteins were assessed in the gastrocnemius muscles of young 
adult and old rats subjected to resveratrol treatment during acute muscle disuse 
induced by HLS. Additionally, muscle function was assessed, pre and post-HLS, to 
determine the efficacy of resveratrol to preserve muscle mass and function following 
disuse.  
• Hypothesis 1.1:  Hindlimb suspension will increase oxidative stress in 
gastrocnemius muscles; Resveratrol administration will improve the redox 
status of these muscles by increasing their endogenous antioxidant defense 
systems.  
• Hypothesis 1.2: The gastrocnemius muscles from old HLS animals will 
exhibit greater increases in oxidative stress than gastrocnemius muscles from 
young HLS animals; Resveratrol administration will attenuate this increase. 
• Hypothesis 1.3:  Hindlimb suspension will increase apoptotic signaling in 
gastrocnemius muscles from both young and old animals; Resveratrol 
administration will reduce apoptotic signaling in these muscles.  
• Hypothesis 1.4:  Resveratrol administration will improve muscle function in 
the gastrocnemius muscles from HLS animals by reducing oxidative stress 
and subsequently reducing myonuclear apoptosis-induced atrophy, leading to 
maintenance of muscle force following HLS. 
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Specific Aim 2:  To determine the ability of long-term resveratrol supplementation 
to counteract the detrimental effects of aging on skeletal muscle mass, function, 
and oxidant load. 
To address aim 2 select antioxidant enzyme capacities, oxidative stress indices, 
mitochondrial-associated signaling proteins and muscle mass and function (force and 
fatigability) were evaluated in the hindlimb muscles of old mice subjected to long-term 
resveratrol supplementation. The dietary supplementation with 0.05% trans-resveratrol 
began at middle-age (18 months old) mice and continued through old age (28 months 
old). Sirtuin1 (Sirt1) were measured because it is potentially activated by resveratrol. 
Therefore, Sirt1 may have a key role in regulating mitochondrial-associated changes in 
response to long-term supplementation. 
• Hypothesis 2.1:   Long-term resveratrol supplementation will reduce oxidative 
stress and consequently oxidative damage in aged skeletal muscle, there by 
slowing the progression of sarcopenia by helping to maintain the muscle mass of 
old mice. 
• Hypothesis 2.2:   Long-term resveratrol supplementation will prevent the age-
associated decline in force production in hindlimb muscles of old mice by 
providing a more favorable muscle redox environment. 
• Hypothesis 2.3:   Long-term resveratrol supplementation will activate Sirt1 and 
in turn will promote mitochondrial biogenesis and improve mitochondrial 
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Chapter 1: Background and Significance 
 
1.1: Sarcopenia; An overview of the consequences and underlying mechanisms: 
 
 Loss of muscle strength and muscle wasting are characteristic of aging and are 
caused by both a loss of muscle fibers and atrophy of the remaining fibers (33; 113). 
Age associated loss of muscle mass and function is termed sarcopenia (113). 
Sarcopenia is a ubiquitous problem facing the elderly and is characterized by marked 
frailty, impaired mobility and an increased risk of injury (58; 113). The combination of 
these factors leads to a severe reduction in the quality of life for older individuals and 
presents an ever increasing burden on our already taxed healthcare system. In the year 
2000, it was estimated that a 10% reduction in the prevalence of sarcopenia would 
result in savings of $1.1 billion per year in U.S. healthcare costs (58). The percentage of 
the U.S population in their seventh and eighth decade of life is increasing at a faster 
rate than at any other time in U.S. history (1), underscoring the importance of finding 
effective countermeasures to combat age-related pathologies, including sarcopenia. 
Although it is known that sarcopenia results in ~40% reduction in skeletal muscle mass 
by the age of 80 (77), the mechanisms underlying this severe muscle atrophy have not 
been completely elucidated. However, age-related increases in pro-oxidant production 
and the resultant oxidative stress associated with this increase are thought to be 
important mediators of the mechanisms triggering sarcopenia and the aging process as 
a whole (45). One pathway known to be activated by oxidative stress (137) and also 
implicated in the progression of sarcopenia (6) is the programmed cell death, or 
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apoptotic pathway. Apoptosis results in cell death for mono-nucleated cells and a loss of 
nuclei in multi-nucleated cells, such as skeletal muscle (6). Since the number of nuclei 
within a muscle fiber is proportional to the size of the fiber, the loss of myonuclei is a 
key factor in skeletal muscle atrophy caused by a wide variety of muscle wasting 
conditions (5; 6), including denervation (2; 126), disuse (38; 128), immobilization (142) 
and advanced age (6). Furthermore, aged individuals must contend with the additive 
effect of the basal incidence of oxidative stress and apoptotic signaling that are inherent 
with advanced age, compounded by the fact that aging potentiates apoptosis during 
disuse, resulting in an enhanced atrophic environment (116; 130). 
 
1.2 Oxidative stress and the process of aging:  
 
Aging is an inevitable process that results in detrimental structural and functional 
changes starting at the subcellular level and eventually affecting the integrity and 
function of tissues, organs and whole systems within animals. Although the pathologies 
associated with aging are well documented (84), the exact mechanisms underlying 
these pathologies are a constant source of debate. One theory that has gained 
popularity over the past two decades, is “the mitochondrial theory of aging”, originally 
presented by Dr. Denham Harmon in 1956. The theory is based on the idea that with 
advanced age there is an increase in free radical production from mitochondria due to 
reductions in the organelles integrity and function and that these free radicals oxidize 
and subsequently damage biomolecules (45; 46; 124). Thus, the accumulation of 
irreversible damage to lipids (94), proteins (52) and nucleic acids (49) drives the aging 
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process. The accrual of damage induced by oxidative stress can ultimately lead to cell 
death in various tissues and cell types, including muscle stem cells (39; 62; 62).  
Furthermore, oxidative stress is positively correlated with skeletal muscle atrophy 
induced by aging (39), denervation (90), disuse and immobilization (69; 71; 100). These 
atrophic stimuli are associated with concomitant increases in lipid peroxidation , 
glutathione oxidation, protein carbonyl formation (133), free iron content (50), xanthine 
oxidase levels (50) and nucleic acid damage (50; 133), which can lead to genomic 
instability and altered gene expression. Compounding the effect of increased pro-
oxidant production and the associated macromolecule damage seen with advanced age 
(39)  and muscle disuse (129) are the inherent alterations in the endogenous 
antioxidant defense systems that occur with aging (95; 103). Although there is an 
incongruence in the literature as to whether the endogenous antioxidant system activity  
increases or decreases with aging, there is an overwhelming amount of literature 
suggesting that despite increases in enzymatic activity and/or content of the antioxidant 
enzymes, the antioxidant defense system in aged individuals can become more easily 
overwhelmed in situations that potentiate oxidant production leading to oxidative stress 
and consequent damage (94; 116; 129). 
 
1.3 The endogenous anti-oxidant system: 
 
 Antioxidant enzymes and compounds are present in organisms as simple as 
single-celled yeasts (57), to the most complex of organisms, humans (95). Their 
ubiquitous presence underscores the importance of protecting oneself from the harmful 
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effects of pro-oxidants. The endogenous anti-oxidant system is composed of a complex 
coordination of enzymes and small molecules, whose sole responsibilities are to keep 
the levels of pro-oxidants in check. Antioxidant enzymes function by converting reactive, 
and thus toxic, pro-oxidants into less reactive forms, in a series of enzymatic reactions 
resulting in more inert biological molecules. An example of this type of chain reaction is 
exemplified by the coordination of two enzymes, superoxide dismutase (SOD) and 
catalase in the stepwise removal of the highly reactive superoxide anion (O2•). The 
superoxide anion is a harmful free radical that is generated in the mitochondria when 
electrons escape the electron transport chain  and react with molecular oxygen, to form 
O2•- (14).  The protonated form (HO2•-) can initiate lipid peroxidation (44; 79) and lead to 
the formation of radical species such as peroxynitrite (ONOO-) and the hydroxyl radical 
(OH•-) (44). Therefore, limiting the production and enhancing the removal of O2•- via 
SOD is a key aspect in limiting the potential downstream oxidation of biomolecules (87).  
Superoxide dismutase has several isoforms that all catalyze the same reaction in 
different subcellular locations; the dismutation of O2• - into the less reactive pro-oxidant 
hydrogen peroxide (H2O2) (11; 87).  Catalase,(located in both the cytosol and in micro-
peroxisomes in skeletal muscle) (20; 108), then further converts H2O2  into O2 and 
water. Alternatively, H2O2 can be reduced by other peroxidases, such as glutathione 
peroxidase, a very abundant enzyme found in the cytosol.  The glutathione redox cycle 
reduces H2O2  by the continual interplay between glutathione reductase and glutathione 
peroxidase. Glutathione peroxidase catalyzes the reaction in which glutathione donates 
an electron to reduce H2O2 and glutathione reductase regenerates glutathione via a 
NADH- dependent reaction, thus this cycle is self-sustaining and extremely beneficial in 
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the prevention of oxidative stress (11). Additionally, there are other non-enzymatic 
molecules present in biological systems that function as anti-oxidants, such as vitamin 
C and vitamin E (102). These small molecules exert their antioxidant capabilities by 
acting as electrons donors, and thus effectively reducing pro-oxidants before they can 
cause oxidative damage. They can also play a role in the repair of oxidized 
biomolecules. (102). Overall, the endogenous antioxidant defenses system is very 
effective in protecting cellular components against oxidation; however, under 
extenuating circumstances, in which pro-oxidant production increases dramatically, or is 
present for prolonged periods of time, the system can become overwhelmed, leading to 
oxidative stress and the associated downstream effects (11). 
 
1.4 Mitochondrial dysfunction; A source of reactive oxygen species with aging: 
 
Age-related mitochondrial alterations underlie a wide variety of diseases such as 
diabetes (81), neurodegeneration (122) and sarcopenia (17). The premise behind this 
relationship is that with advanced age there are more dysfunctional mitochondria 
present within a cell (80). These defective mitochondria contain “leaky” electron 
transport chains and thus more pro-oxidants are produced leading to oxidative stress 
(17; 49). The process is cyclic, with more mitochondrial uncoupling, there are more pro-
oxidants present to further damage vulnerable membrane phospholipids (49; 94) and 
perhaps more importantly oxidatively damage mtDNA, which unlike nuclear DNA, is 
without the protection of chromatin condensation and histones (26). Thus, damaged 
mtDNA can lead to a further decrease in the quality and quantity of mitochondria within 
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a cell, potentiating an oxidizing environment. Although mitochondria are not the sole 
source of ROS within a cell, they are routinely viewed as the principle site of superoxide 




Figure 1.1- Mitochondria mediated ROS generation. 
 
Mitochondrial derived superoxide generation increases with advanced age (91). 
Additionally, mitochondria have recently been shown to be the primary source of ROS 
within muscle precursor cells (143) (146). The potential for ROS to damage satellite 
cells is of particular concern in a post-mitotic tissue like skeletal muscle, as satellite cells 
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represent the only  mechanism for muscle repair, adaptation and regeneration; thus the 
only mechanism available to combat sarcopenia (114; 123). Further evidence linking 
mitochondrial dysfunction and skeletal muscle atrophy is the negative association 
between muscle fiber size and the content of dysfunctional mitochondria (48; 88). 
 
1.5 Oxidative stress and muscle atrophy: 
 
 Oxidative stress is associated with skeletal muscle atrophy caused by a variety of 
underlying conditions (89; 136). During extended periods of oxidative stress there is an 
eventual loss of cellular integrity mediated by the oxidation of lipids (94; 118), proteins 
(29; 89) and nucleic acids (50), promoting a cycle of increased pro-oxidant production, 
and thus increased oxidative damage, which limits both the cellular repair system and 
the enzymatic antioxidant defense system (39). The exact mechanisms by which 
oxidative stress acts as a potentiator of muscle atrophy are largely unknown, however, 
several relationships between oxidative stress and atrophy have been postulated (39; 
101). Specifically, skeletal muscle atrophy is characterized by an overall reduction in 
protein synthesis and/or a concomitant increase in protein catabolism resulting in a net 
protein loss (10; 63). Oxidized proteins are preferentially targeted by the 20S 
proteasome (60) and are subsequently degraded via proteolysis (60).  However, 
severely oxidized proteins are poorly recognized by the proteasome system and thus 
can aggregate and lead to an accumulation of dysfunctional proteins (42; 95; 132). 
Additionally, several  key signaling pathways responsible for regulating muscle 
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precursor cell proliferation, differentiation and survival are redox sensitive, including the 
forkhead family of transcription factors (FOXOs) (141; 145) and nuclear factor-ĸB 
(NFĸB) (76; 115; 136). Therefore, in an oxidizing environment these proteins have the 
potential to promote cell cycle arrest and decrease the proliferation of satellite cells, 
potentiating muscle atrophy. Furthermore, key mitogen-activated kinases (MAPKs), 
involved in the cellular stress response, are positively regulated by oxidative stress (31; 
137) and when activated, act as upstream activators of the apoptotic pathway (118), 
which is associated with skeletal muscle atrophy. Clearly, the potential is there for 
oxidative stress to negatively impact the proliferation and differentiation capacity of 
satellite cells, the muscles only source of regenerative potential (24; 76; 140), has it 
therefore could influence muscle size and function. 
 
1.6 Oxidative stress and muscle function: 
 
Given that oxidative stress is positively correlated with muscle atrophy (32; 39; 
129), it is likely negatively associated with muscle force production (21; 23; 53; 107). 
Furthermore, increased pro-oxidant production and/or an attenuated capacity to buffer 
these pro-oxidants, may result in reductions in muscle function beyond the linear 
relationship between cross-sectional area and muscle force generation (22; 53; 107) 
due to alterations of neural and/or metabolic factors (22).  
This reduced functional capacity may be particularly true in aged skeletal muscle, 
where the increase in pro-oxidant production can overwhelm the endogenous anti-
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oxidant defense system, leading to cellular damage, increased muscle frailty and thus a 
decreased functional capacity (39; 49).  
 Specifically, increases in oxidative stress have the potential to depress muscle 
specific force (21; 99), alter myofilament function as a result of loading (70; 72)  and 
perturb calcium handling induced by muscle contractions leading to calpain activation 
(35; 36; 97; 125). Additionally, it is possible that oxidative stress could alter muscle 
function by impeding recovery from injury (64) and other pathological conditions, given 
that muscle precursor cells are sensitive to oxidative stress (86; 104; 140) . 
 
1.7 Oxidative stress and apoptosis; the mitochondrial link: 
 
 
Figure 1.2- Mitochondria as mediators of oxidative stress and apoptosis. 
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Myonuclei undergo apoptosis in many muscle wasting conditions including, but 
not limited to, advanced age (6), disuse (128) and denervation (92; 126). Likewise, 
these conditions are also associated with increases in oxidative stress (101), 
presumably generated through mitochondrial dysfunction, given the importance that the 
mitochondria play in maintaining cellular integrity via ROS production and the regulation 
of the apoptotic pathway (3; 8; 139). Mitochondria house several proteins, which in 
times of cellular stress, are released in to the cytosol through the mitochondrial 
transition pore (mtPTP) in the outer mitochondrial membrane (8; 66; 118). These 
proteins include several modulators of the apoptotic signaling pathway, including 
apoptosis inducing factor (AIF), Cytochrome c, endonuclease G, and smac/diablo which 
initiate a cascade of proteolytic events that converge on the nucleus leading to the 
fragmentation of DNA and ultimately cell death (8; 66). Regulation of the mtPTP 
opening is mediated via the B-cell lymphoma-2 (Bcl-2) family of proteins (47; 66), which 
contains both anti and pro-apoptotic members. Specifically, the pro-apoptotic member, 
Bax, is responsible for the mitochondrial transition pore channel formation via homo-
oligermization and subsequent insertion into the outer mitochondrial membranes 
resulting in pore formation (see Figure 1.2) (47; 66). Conversely the channel is 
negatively regulated by the anti-apoptotic Bcl-2 protein, which acts to inhibit mtPTP 
formation by dimerizing with Bax (8; 66), thus preventing Bax from translocating and 
inserting into the membrane.    
One pathway that directly links oxidative stress and apoptosis starts with the 
phosphorylation and subsequent activation of two members of the redox sensitive 
MAPK pathway; c-jun kinase (JNK) and p-38 (121). Both JNK and p38 are activated by 
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apoptosis signaling kinase 1 (ASK-1) (18), a kinase upstream of the mitochondria (18). 
In a reducing environment ASK-1 remains inactive due to its dimerization with reduced 
thioredoxin (TRX) an anti-oxidant compound that  functions in a very similar manner to 
the glutathione redox system and effectively reduces peroxides, such as H2O2  (27; 
150). However, in an oxidizing environment TRX is oxidized and can no longer bind 
ASK-1, leaving the kinase free to phosphorylate its downstream targets, which include 
both JNK and p38 (27; 121; 150). Both Bax and Bcl-2 have multiple phosphorylation 
sites (30; 147; 148), which when phosphorylated confer conformational changes that 
can either promote, or inhibit their ability to regulate the mtPTP opening and 
consequently apoptosis (65). JNK and p-38 have been shown to each have the 
capability to phosphorylate both Bcl-2 and Bax (65). Bcl-2 phosphorylation causes the 
protein to lose its affinity for Bax, preventing Bcl-2 from sequestering Bax in the cytosol 
and thus abrogating its anti-apoptotic potential (43). Conversely, the phosphorylation of 
Bax causes a conformational change that exposes its N-terminus and promotes its 
ability to insert into the outer mitochondrial membrane and initiate apoptosis (65)      
It should be noted that these pathways, although well characterized in vitro, have 
been very hard to elucidate in vivo and to date no study exists (to the author’s 
knowledge), characterizing the actual, not theoretical, role that the ASK-1 pathway may 
play in myonuclear apoptosis in skeletal muscle. The lack of direct evidence is likely 
due, in part, to the lack of effective antibodies for use in rodent skeletal muscle given 
that ASK-1 gene expression is well characterized in skeletal muscle (13). ASK-1 protein 
levels do not appear to be present in high concentrations in skeletal muscle, making 
elucidating the role that ASK-1 may play in the oxidative stress apoptotic continuum 
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hard to clarify. Although direct manipulations of the signaling that occurs in skeletal 
muscle in response to oxidative stress is difficult to ascertain, taken as a whole the 
literature shows evidence that a causal relationship between an oxidant mediated 
stressor and the initiation of both the extrinsic (inflammatory mediated) and intrinsic 
(mitochondrial mediated) apoptotic pathways does exist. 
  
 
1.8 Countermeasures to oxidative stress: 
  
 Gaining clearer insight into the molecular signaling pathways involved in aging 
and disuse-mediated muscle atrophy is paramount in developing nutritional and/or 
pharmacological interventions to minimize protein loss and attenuate the functional 
decrements associated with atrophic conditions. To date, numerous studies have been 
undertaken to evaluate the efficacy of various compounds, including antioxidants 
(vitamin E & C) (9; 124; 133), enzyme antagonists (allopurinol) (85) and other signaling 
modulators (NFk-B inhibitors) (59), in improving physiological and functional outcomes 
following atrophic stimuli. The results of these interventional studies vary from showing 
no beneficial effects of supplementation interventions (37) , to showing promising 
protective effects with regard to muscle mass (9; 124; 149) and function (9; 85). 
Although the potential seems clear for antioxidant and other signal modifying 
compounds to provide protection against oxidative stress by acting as free radical 
scavengers, antioxidant enzyme enhancers, or promoters of mitochondrial biogenesis, 
there are many variables to consider. The bioavailability of a compound, the chosen 
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route of administration and its metabolism within an animal (82), may alter their efficacy 
as anti-atrophic countermeasures, potentially explaining the lack of congruency in the 
literature (51). 
 If in fact one believes that mitochondria are the primary source of ROS within a 
cell and that their integrity and content are directly related to the aging process (45; 49), 
then an ideal countermeasure to both aging and disuse-associated oxidative stress and 
subsequent muscle atrophy would be a compound with direct free radical scavenging 
capabilities, the capacity to upregulate the endogenous antioxidant defense system and 
directly improve mitochondrial content and function, leading to a reduction in pro-oxidant 
production. Fortunately, it seems such a compound exists; resveratrol. 
 
1.9 Resveratrol, an antioxidant and activator of Sirtuin 1: 
 
 Resveratrol (3,5,4,trihydroxystilbene) is a naturally occurring polyphenol found in 
over seventy plant species, including grapes, peanuts and mulberries. It belongs to the 
stilbene family of phytoalexins, which are anti-microbial compounds produced in plants 
in response to bacterial, or fungal infections (15). Resveratrol has gained popularity 
over the past decade due to its potent anti-oxidant and anti-aging properties (83; 96; 
109).  Recent studies have shown resveratrol to improve the outcomes of pathological 
conditions ranging from cancer (16; 95; 112; 138; 149), chronic inflammation (34; 105; 
111) and neurodegenerative diseases (111). Specifically, resveratrol has been shown to 
mediate cardiomyocyte survival following simulated hypoxia/reperfusion by up- 
regulating both the antioxidant thioredoxin and the anti-apoptotic protein Bcl-2 (27).  
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Resveratrol also stimulated glutathione synthesis in alveolar epithelial cells exposed to 
cigarette smoke extract (68; 95). Additionally, several recent studies demonstrated the 
ability of resveratrol to specifically induce the transcription of two key antioxidant 
enzymes, catalase (68; 73; 95; 117) and MnSOD (68; 95; 109; 110; 117), both in vitro 
and in vivo.  
With regard to skeletal muscle, resveratrol administration has effectively 
attenuated protein degradation in murine myotubes treated with proteolysis-inducing 
factor and attenuated muscle atrophy, in vivo, in a mouse model of cachexia (149).  
Furthermore, acute dietary resveratrol supplementation attenuated lipid peroxidation 
and improved the redox status, (quantified by the reduced to oxidized glutathione ratio), 
in aged murine skeletal muscle exposed to a repetitive loading protocol (117). Likewise, 
acute resveratrol administration was able to attenuate lipid peroxidation and reduce 
H2O2 concentrations in skeletal muscles from aged animals undergoing extended 
unloading (54). In an in vitro model of anti-viral therapy, the addition of resveratrol to 
primary myoblasts isolated from human quadriceps muscles which were treated with 
protease inhibitors, the hallmark treatment of those individuals infected with the Human 
Immunodeficiency Virus (HIV), resveratrol completely ablated the increase in ROS that 
is known to occur following protease inhibitor treatments.  Moreover, supplementation 
with a combination of a low dose of resveratrol and coenzyme Q improved both the 
inflammatory status and morphological profile in quadriceps muscles from dystrophic 
mice (98). The protective effect of resveratrol with regard to the aforementioned 
parameters is significant because muscle regeneration is the one of the key deficiencies 
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with muscular dystrophies and therefore it is possible that resveratrol may enhance the 
capacity of muscle to regenerate under pathological conditions.  
Despite the fact that resveratrol has the biochemical capacity to directly 
scavenge free radicals due to its phenol ring structure and in fact, resveratrol has 
repeatedly been shown to be a potent scavenger of ROS in numerous cell types 
exposed to pro-oxidants (16; 61; 83; 110). However, its rapid first pass metabolism in 
mammals and thus relatively low bioavailability (28; 40; 82), may limit its role as a direct 
ROS scavenger in vivo. Consequently, in vivo, the various health benefits of resveratrol 
can more likely be attributed to its ability to activate the NAD dependent deacetylase, 
silent mating type information regulation homolog1, or sirtuin1 (Sirt1) (4; 74).  
Sirt1 has been shown to play a role in a variety of important physiological 
functions including gluconeogenesis, energy expenditure, lipid oxidation, mitochondrial 
biogenesis and the regulation of oxidative stress and survival across a wide array of cell 
types (67; 74; 93; 144; 150). Sirt1 effectively protects certain mammalian cells from 
apoptosis by deaceytylating and thus inactivating p53 (41), furthermore, Sirt1 
specifically protects against Bax-induced apoptosis through activation of the Bax 
transcriptional inhibitor Ku70 (7). Additionally, Sirt1 upregulates the transcription of both 
MnSOD and catalase (41), further showcasing its potential as a protective mechanism 
against oxidative stress. Sirt1 is also activated with exercise (134) and under conditions 
of nutrient deprivation (19; 145), underscoring its effectiveness as a caloric restriction 
mimetic. This is significant because both exercise (127; 131) and caloric restriction (12; 
19; 75)  are proven countermeasures to combat both oxidative stress and myonuclear 
apoptosis. Therefore, we would expect resveratrols’ ability to activate Sirt1, to effectively 
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reduce muscle loss during both disuse and aging. In a recent study, resveratrol 
stimulated muscle precursor cell proliferation in a Sirt1 dependent manner (106), further 
expanding the mechanisms by which resveratrol supplementation may improve muscle 
mass and function by enhancing muscles regenerative capacity, which has been shown 
to be augmented with aging (24; 25) and in certain pathological conditions. 
Furthermore, and perhaps most importantly, Sirt1 is a powerful regulator of PPARγ co-
activator (PGC-1α) (135), which is considered to be the master regulator of 
mitochondrial function (78). PGC-1α is decreased during atrophic conditions (119; 120), 
but muscle specific overexpression of PGC-1α confers protection against both 
denervation and fasting-induced skeletal muscle atrophy (120). Therefore, the ability of 
Sirt1 to promote mitochondrial biogenesis, including structural components of the 
electron transport chain, ATPases, oxidative enzymes and the induction of MnSOD, 
provides compelling evidence with regard to resveratrols’ potential ability to protect 
skeletal muscle from oxidative stress-induced damage and thus myonuclear apoptosis 











As of 2008 the United States Department of Health and Human Services projects 
that the number of individuals over the age of 65 will double in the next 20 years, 
making sarcopenia a debilitating and costly reality for an ever increasing percentage of 
our population. A relationship between increases in oxidative stress and decreases in 
muscle mass and function clearly exists, thus it is increasingly imperative that effective 
therapies are found to alleviate oxidative stress and thus improve the quantity and 
quality of skeletal muscle in elderly individuals. Overall, the reliance of skeletal muscle 
viability on proper muscle function skeletal muscle viability highlights the importance of 
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promoting mitochondrial biogenesis and conserving mitochondrial membrane integrity 
as important countermeasures to reduce skeletal muscle atrophy associated with disuse 
and aging. Sirt1 activation is positively associated with an increased resistance to 
oxidative stress and apoptosis, likely due to its capacity to promote mitochondrial 
biogenesis. Resveratrol is a potent activator of Sirt1 and thus shows promise as an 
effective therapy to lessen mitochondrial-induced oxidative stress and apoptosis. There 
has been limited animal research conducted regarding the protective effects of 
resveratrol supplementation on skeletal muscle. Given the inherent differences between 
cell culture models and whole animals models, it is important to elucidate the specific 
signaling pathways of resveratrol, in vivo, to further our understanding of its’ capacity to 
protect against skeletal muscle atrophy. 
The major goals of this research are to further understand the interplay between 
oxidative stress and skeletal muscle atrophy and to evaluate the efficacy of resveratrol 
as a countermeasure to both mitochondrial-induced oxidative stress and apoptosis. It is 
hypothesized that with skeletal muscle disuse and advanced age there will be an 
increase in both oxidative stress and a concomitant decrease in muscle mass and 
function. Resveratrols’ capacity to upregulate the endogenous anti-oxidant defense 
system, increase mitochondrial biogenesis and thus enhance cell viability, makes it an 
ideal candidate to combat oxidative stress and sarcopenia (see Figure 1.4). Thus it is 
hypothesized that resveratrol will improve muscle mass and function with both disuse 
and aging-induced muscle atrophy.  It is expected that the results of the current study 
will help to further our understanding of the usefulness of dietary supplements as 
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Hindlimb suspension (HLS) elicits muscle atrophy, oxidative stress, and apoptosis in 
skeletal muscle.  Increases in oxidative stress can have detrimental effects on muscle 
mass, function and can potentially lead to myonuclear apoptosis.  Resveratrol is a 
naturally occurring polyphenol possessing both anti-oxidant and anti-aging properties.  
To analyze the capacity of resveratrol to attenuate oxidative stress, apoptosis and 
muscle force loss were measured following 14 days of HLS. Young (6 mo) and old (34 
mo) rats were administered either 12.5mg/kg/day of trans-resveratrol, or 0.1% 
carboxymethylcellulose for 21days, including 14 days of HLS.   HLS induced a 
significant decrease in plantarflexor isometric force, but resveratrol blunted this loss in 
old animals. Resveratrol increased gastrocnemius catalase activity, MnSOD activity, 
and MnSOD protein content following HLS. Resveratrol reduced hydrogen peroxide and 
lipid peroxidation levels in muscles from old animals after HLS. Caspase 9 abundance 
was reduced and Bcl-2 was increased, but other apoptotic markers were not affected by 
resveratrol in the gastrocnemius muscle after HLS. The data indicate that resveratrol 
has a protective effect against oxidative stress and muscle force loss in old HLS 
animals; however, resveratrol was unable to attenuate apoptosis following HLS. These 
results suggest that resveratrol has the potential to be an effective therapeutic agent to 








Both advanced age and skeletal muscle disuse are associated with atrophy and 
an increased production of reactive oxygen species (ROS) in skeletal muscle (27), 
leading to an augmented oxidant-load.  Oxidative stress occurs when an increase in 
oxidant production exceeds an organisms’ capacity to buffer them, via a complex 
coordination of the endogenous antioxidant defense system. During extended periods of 
oxidative stress there is an eventual loss of cellular integrity mediated by the oxidation 
of lipids (29), proteins (26) and nucleic acids (18), promoting a cycle of increased 
oxidant production. This results in elevated levels of oxidative damage, which limits both 
the cellular repair system and the enzymatic antioxidant defense system (14). The exact 
mechanisms by which oxidative stress acts as a potentiator of muscle atrophy are 
largely unknown, however, several links between oxidative stress and atrophy have 
been postulated  (32). 
Oxidative stress is upstream of apoptotic signaling in muscle cells in vitro (46), 
and results in the initiation of the intrinsic mitochondrial apoptotic pathway.  Of particular 
interest  in the current study was to determine if redox sensitive apoptotic signaling (49) 
could  be suppressed by resveratrol administration during experimentally-induced 
muscle disuse. This is an important area of inquiry, because myonuclei undergo 
apoptosis during muscle disuse (42,44), and this is thought to contribute to fiber 
atrophy, especially in aging muscles (2,3). Likewise, muscle disuse is associated with 
increases in oxidative stress (1,27), presumably mediated through mitochondrial 
dysfunction via ROS production and the regulation of the apoptotic pathway (17,44). 
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Antioxidant supplementation has been shown to be an effective counter measure 
to combat oxidative stress in a wide variety of tissue types and conditions (7,33),  and it 
is speculated that this might be an approach to reduce muscle wasting associated with 
both disuse (40) and aging (7). Resveratrol (3,5,4,trihydroxystilbene) is a naturally 
occurring polyphenol found in over seventy plant species, including grapes, peanuts 
and mulberries (5). Resveratrol has gained popularity over the past decade due to its 
potent anti-oxidant and anti-aging properties  (24,36). Recent studies have shown 
resveratrol to have positive effects on the outcomes of pathological conditions ranging 
from cancer (6)  chronic inflammation  (19) and neurodegenerative diseases (37). 
Specifically, resveratrol has been shown to mediate cardiomyocyte survival following 
simulated hypoxia/reperfusion by up regulating both the antioxidant thioredoxin and the 
anti-apoptotic protein Bcl-2 (4,10), thus underscoring its potential to act as both an 
antioxidant and anti-apoptotic compound. Likewise in a recent study in PC12 cells 
exposed to hydroxynonenal , an oxidizing byproduct of lipid peroxidation, pretreatment 
with resveratrol decreased the amount of the pro-apoptotic Bax protein, decreased 
caspase 3 activity and increased the amount of anti-apoptotic Bcl-2 protein, conferring 
complete protection against oxidative stress and apoptotic signaling (41).  Additionally, 
recent data suggest that resveratrol induces the transcription of two key antioxidant 
enzymes, catalase (9,21) and MnSOD (36,39).  Furthermore, a recent study in our 
laboratory found acute dietary supplementation with resveratrol to effectively reduce 
indices of oxidative stress in repetitively loaded skeletal muscles, presumably through 
the upregulation of antioxidant enzymes including MnSOD, an important mitochondrial 
antioxidant in muscles from both young and old animals (39). The efficacy of acute 
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resveratrol administration has been established for several pathological conditions; 
however, the use of chronic resveratrol administration as a counter-measure to prevent 
muscle loss caused by disuse has not been established. 
Therefore, the primary aim of this study was to evaluate the efficacy of a daily 
moderate dose of resveratrol to ameliorate oxidative stress and subsequent myonuclear 
apoptosis induced by skeletal muscle disuse in both young and old animals. In the 
present investigation, it was hypothesized that resveratrol would reduce the indices of 
hindlimb suspension (HLS)-induced oxidative stress in skeletal muscle and thus lessen 
the potential for downstream apoptotic signaling and subsequent muscle atrophy 
stemming from myonuclear loss.  Furthermore, it was hypothesized that resveratrol 
administration would preserve muscle function following HLS both by preservation of 






Animals.  All experiments were conducted on young adult (6mo) and old (34mo) 
Fischer Brown Norway x 344 male rats. The animals were obtained from the NIA colony 
house at Harlan (Indianapolis, IN) and kept in pathogen-free conditions at ~20°C, on a 
reversed twelve-hour light cycle. All experimental procedures carried approval from the 
Institutional Animal Use and Care Committee from West Virginia University School of 
Medicine. The animal care standards followed the recommendations for the care of 
laboratory animals as advocated by the American Association for Accreditation of 
Laboratory Animal Care (AAALAC) and fully conformed to the American Physiological 
Society's "Guiding Principles for Research Involving Animals and Human Beings.” 
 
Hindlimb Suspension.   The hindlimb suspension technique employed in the current 
study is a modification of the technique originally described by Morey-Holton and 
Globus (25). This method allows for an even load distribution on the tail, permits the 
animals with 360° of movement around the cage, and assures that the forelimbs 
maintain contact with a grid floor, allowing the animals to move and access food and 
water freely as previously described (44,45). Briefly, orthopedic tape was applied along 
the proximal one-third of the tail then placed through a wire harness that is attached to a 
swivel placed at the top of a specially designed hindlimb suspension cage. Sterile gauze 
was then wrapped around the orthopedic tape and was subsequently covered with a 
thermoplastic material, which formed a hardened cast (Vet-Lite; Veterinary Specialty 
Products, Boca Raton, FL).  The distal tip of the tail was examined daily to verify that 
the procedure did not occlude blood flow to the tail. The suspension height was 
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adjusted to prevent the animal’s hindlimbs from touching any supportive surface, with 
care taken to maintain a suspension angle that did not exceed 30°. Weight bearing 
control animals were allowed to ambulate freely in their cages. 
 
Experimental Protocol.  Prior to commencement of the experimental protocol, all 
animals went through a 7-day acclimation period, which included the daily oral gavage 
of 1mL of distilled H2O.  Animals were hindlimb suspended (HLS) for 14 days. Seven 
days preceding suspension and continuing throughout the suspension protocol, all 
animals received either 1mL of 0.1% Carboxymethylcellulose dissolved in deionized 
water, or 1mL of trans-resveratrol suspended in 1mL of 0.1% Carboxymethylcellulose.  
Resveratrol was purchased from Orchid Pharmaceuticals (India).  The resulting 
solutions were administered via oral gavage at a dose of 12.5mg/kg/day, for a total of 
21 days. This dosage was chosen to provide a low to moderate daily dose of resveratrol 
that would have the potential to be therapeutic, but would not be high enough to be pro-
apoptotic as can be seen with higher doses of resveratrol (13). Age-matched, non-
suspended animals served as weight-bearing controls (Figure 1). 
 
Refer to Figure 1 
 
Force Analysis. Pre and post-HLS force measurements were assessed in anesthetized 
animals using a custom built rat dynamometer (8,38).  The rat was placed supine on a 
heated X–Y positioning table of the rodent dynamometer, and anesthesia was induced 
with 5% isoflurane. Anesthesia was maintained in the animals over the duration of the 
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experiment with 2% isoflurane. The left foot was secured to the footplate at an ankle 
angle of 90° and the knee was braced to ensure that forces were transmitted to the 
footplate. Vertical forces applied to the aluminum sleeve fitted over the dorsum of the 
foot were translated to a load cell transducer in the load cell fixture on the footplate. 
Platinum stimulating electrodes (Grass Medical Instruments, Quincy, MA) were inserted 
subcutaneously to span the tibial nerve in the popliteal fossa. The maximal isometric 
force of the plantar flexor muscle group was evaluated by stimulating the tibial nerve 
using supramaximal square wave pulses at 100Hz for a duration of 1000 ms using a 
SD9 stimulator (Grass Medical Instruments, Quincy, MA). The voltage used in these 
experiments was 10% greater than the voltage required to obtain maximal force 
production. Maximal force was determined off-line via custom Labview based software 
(8). The maximal forces for three isometric contractions were averaged for each data 
point. These in vivo  force records were obtained before and after HLS. The percent in 
force loss with HLS was obtained by comparing the average pre-HLS for record with the 
post-HLS force record. 
 
Muscle preparation.  Immediately following the last contraction, the gastrocnemius 
muscle was dissected from both limbs muscle, weighed and snap frozen. To eliminate 
the possibility that the isometric muscle function tests could acutely affect 
measurements of oxidative stress, the gastrocnemius muscle from the limb that was not 
evaluated for muscle function (the right limb) was used for analysis of oxidative enzyme 
activities, oxidative stress, and apoptotic indices. The animals were then euthanized by 




Protein Isolation.  Seventy-five micrograms of gastrocnemius muscle from each animal 
was homogenized in RIPA buffer (1% Triton x-100, 150mM NaCl, 5mMEDTA, 10mM 
Tris; pH: 7.4) for assessment of protein expression, caspase activity and cell death as 
measures by an ELISA. For all oxidative enzyme activity assays and/or redox status 
assessments muscle samples were homogenized in either PBS, or the kit specific buffer 
provide by the manufacturer. Muscle samples were homogenized in 500 μL of the 
appropriate ice-cold lysis buffer using a mechanical homogenizer. Muscle homogenates 
were centrifuged at 1000 x g for 5 minutes at 4°C. The resulting supernatant was 
collected and divided into two portions and frozen at –80°C  either with, or without a 
protease inhibitor cocktail containing 104 mM 4-[2-aminoethyl]-benzenesulfonyl fluoride 
hydrochloride, 0.8 mM aprotinin, 2 mM leupeptin, 4 mM bestatin, 1.5 mM pepstatin A, 
and 1.4 mM E-64 (Sigma-Aldrich, St. Louis, MO) added to it. Protein concentrations for 
each sample were determined in duplicate using the DC Protein Assay kit (Bio-Rad, 
Hercules, CA). 
Catalase Activity. The activity of catalase was determined in gastrocnemius muscle 
homogenates using a commercially available kit (# 707002 Cayman Chemical 
Company, Ann Arbor, MI) as described previously in our laboratory (39). The samples 
were read on a microplate reader (DYNEX technologies, Chantilly VA) at an 
absorbance of 520nm. All analyses were measured in duplicate and the samples were 




Manganese Superoxide Dismutase (MnSOD) and Copper-Zinc Superoxide 
Dismutase (CuZnSOD) Activity Levels.  Superoxide dismutase activity was measured 
in gastrocnemius muscle homogenate using a colorimetric enzyme activity kit (Cayman 
Chemical Company Ann Arbor, MI) following the manufacturer’s guidelines. Both total 
SOD activity and MnSOD activity were obtained. CuZnSOD activity was determined by 
subtracting MnSOD activity from total SOD activity.  The assay was performed with 
slight modifications to the manufacturer’s directions. All analyses were measured in 
duplicate and the samples were normalized to µg of protein per μL of muscle 
homogenate as described previously by our laboratory (14).  Briefly, muscle samples 
were homogenized in 20mM HEPES buffer, containing 1mM EGTA, 210mM mannitol, 
and 70 mM sucrose, and centrifuged at 1000 x g for 10 min. 50 µl of the resulting 
supernatant was incubated either with, or without, 12 mM potassium cyanide to inhibit 
CuZnSOD and extracellular SOD activity.  The sample absorbance was measured at 
450 nm using a 96-well plate reader (Dynex Tech., Chantilly VA., USA). 
 
Immunoblots. The protein content of the oxidative enzymes Catalase, CuZnSOD, and 
MnSOD and the apoptotic markers Bax and Bcl-2 were assessed in gastrocnemius 
muscle homogenates. Either β-tubulin or GAPDH was used as loading controls. 
Although most blots were probed with β-tubulin, GAPDH was used as a loading control 
for blots in which we probed for Bax, because we had intended on also measuring 
apoptosis inducing factor (AIF) on the same blot, because AIF and Bax run at different 
molecular weights. However, AIF runs at a similar molecular weight as β-tubulin (data 
not shown) and therefore, we could not use β-tubulin as the loading control for these 
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blots.   Thirty to forty micrograms of protein were loaded into each well of a 4%–12% 
gradient polyacrylamide gel (Invitrogen, Carlsbad, CA) and separated by routine sodium 
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) for 1.5hrs at 20°C, 
followed by transfer to a nitrocellulose membrane for 70min at 35V. All membranes were 
blocked in 5% nonfat milk (NFM) for 1 hour at room temperature. The membranes were 
then incubated overnight at 4°C in the appropriate primary antibodies. Primary 
antibodies were diluted in Tris-buffered saline, with 0.1% Tween-20 (TBST) and 10% 
sodium azide. Membranes were then washed in 0.05% TBST followed by incubation in 
the appropriate dilutions of secondary antibodies (diluted in 5% NFM in TBST) 
conjugated to horseradish peroxidase. The signals were developed using a 
chemiluminescent substrate (Lumigen TMA-6; Lumigen, Southfield, MI) and visualized 
by exposing the membranes to x-ray films (BioMax MS-1; Eastman Kodak). Digital 
records were captured by a Kodak 290 camera, and protein bands were quantified using 
1D analysis software (Eastman Kodak). Bands were quantified as optical density x band 
area and expressed in arbitrary units relative to the loading control bands. 
 
Hydrogen Peroxide (H2O2) Content.  H2O2 content in gastrocnemius muscle 
homogenate was measured using a fluorescent assay according to the manufacturer’s 
recommendations (Cell Technology, Mountain View, CA). Briefly, 50 μL of control, 
unknown muscle samples, or H2O2 standards were mixed with 50 μL of the reaction 
cocktail provided in the kit and added to each well to initiate the reaction. The plate was 
then incubated in the dark for 10 minutes at room temperature. The intensity of the 
fluorescent signal was detected using an excitation wavelength of 530 nm and an 
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emission wavelength of 590 nm. A linear regression was performed by plotting the 
resultant florescent intensities from the known standards and subsequently the 
unknown samples were fit to the corresponding linear equation. All analyses were 
measured in duplicate and the samples were normalized to µg of protein per μL of 
muscle homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules, 
CA). 
Lipid Peroxidation. Malondialdehyde (MDA) and 4-hydroxyalkenals (HAE) were 
assessed with reagents from Oxis International (BIOXYTECH LPO-586). Approximately 
100 mg of gastrocnemius muscle was homogenized in 750 μL of ice cold buffer 
containing phosphate-buffered saline (20 mM, pH 7.4) and 5 μL of 0.5 M butylated 
hydroxytoluene in acetonitrile per 1 mL of tissue homogenate. Assay reagents were 
added following the manufacturer's recommendations. Briefly, the muscle homogenate 
was centrifuged at 3000 x g at 4°C for 10 minutes, and subsequently the supernatant 
was used to assess lipid peroxidation. The sample was incubated in the proper 
reagents at 45°C for 60 minutes, and then centrifuged at 15,000 x g for 10 minutes. The 
absorbance of the resulting supernatant was read at 586 nm. All analyses were 
measured in duplicate and the samples were normalized to µg of protein per μL of 
muscle homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules, 
CA). 
Caspase Activity. The proteolytic activity of caspase 9 and 3 were assessed with a 
fluorometric activity assay using the commercially available substrates; AC VDVAD-
AFC and AC-DEVD-AFC (Alexis Biochemical, San Diego, CA) respectively.  Briefly, 
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50μL of caspase activity buffer (50 mM PIPES, 0.1 mM EDTA, 10% glycerol, 1 mM 
DTT) was added to each well of a 96-well fluorescent microplate (Thermo Fisher 
Scientific). Subsequently, 50μL of gastrocnemius muscle homogenate and 10μL of the 
appropriate caspase substrate (1mM) were added to each well.  Caspase activity was 
determined by measuring fluorescent intensity using a fluorescent microplate reader at 
an excitation of 400nm and an emission of 505nm. The microplate was incubated at 
37°C for 2-hours with caspase activity determined by subtracting the OD readings at 
time 2-hour from the initial reading, to eliminate any background fluorescence that was 
not mediated by caspase activity. All analyses were measured in duplicate and the 
samples were normalized to µg of protein per μL of muscle homogenate as determined 
by the DC Protein Assay Kit (Bio-Rad Hercules, CA). 
 
Cell-Death ELISA Assay. A commercially available ELISA kit (Cell Death Detection 
ELISA, Roche Diagnostics, Indianapolis, IN) was used to quantify DNA fragmentation in 
gastrocnemius muscle homogenate. Briefly, the wells of a 96-well plate were coated 
with a primary anti-histone mouse monoclonal antibody.  Following the addition of 100 
μL of muscle homogenate, a secondary anti-DNA mouse monoclonal antibody coupled 
to peroxidase was added to each well.  The substrate, 2,2’-azino-di-(3-
ethylbenzthiazoline sulfonate) (ABST) was used to photometrically determine the 
amount of peroxidase retained in the immunocomplex.  The colorimetric change of each 
well was determined at a wavelength of 405nm using a Dynex MRX plate reader and 
computer software (Revelation, Dynatech Laboratories, CA).  All analyses were 
measured in duplicate and the samples were normalized to µg of protein per μL of 
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muscle homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules, 
CA). The resulting OD was recorded as the apoptotic index (OD405 / mg protein).  This 
assay measures DNA fragmentation in myonuclei, satellite cells, and non-muscle cell 
nuclei. However,  because DNA fragmentation as determined by this ELISA is directly 
proportional to TUNEL identification of apoptotic muscle nuclei in old rat muscle after 
hindlimb suspension (30),  the data obtained in the ELISA assay are a reasonable 
indicator of the apoptotic environment in skeletal muscle of the experimental animals. 
 
Statistics.  Statistical analyses were performed using the SPSS 13.0 software package 
(SPSS, Chicago, IL). A multiple analysis of variance was used to examine differences 
between age, suspension and supplementation. Tukey’s post-hoc analyses were 
performed to protect against type 1 errors.   Where appropriate, student t-tests were 
implemented to evaluate paired comparisons. Statistical significance was accepted at p 





Body Weight. Resveratrol was unable to suppress the body weight loss associated 
with  HLS. All animals were weighed prior to the experimental protocol and immediately 
before euthanasia (Table 1). Older animals were significantly heavier than young 
animals (460 ± 38g vs.  548 ± 39g; p ≤ 0.05). Young vehicle control suspended (YVCS) 
animals lost ~15% of their body weight during the 14-day suspension protocol, while old 
vehicle control suspended (OVCS) animals lost ~ 13.5% of their body weight during the 
14-day suspension protocol. There was no significant effect of resveratrol administration 
on the body weight of young vehicle control  (YVC),  YVCS,  old vehicle control (OVC) 
or old OVCS  animals. There was no significant difference between the percent of total 
body weight lost during the 21-day experimental protocol when comparing groups of 
HLS animals (Table 1). 
 
Refer to Table 1 
 
CuZnSOD Enzyme Activity and Protein Content. Both aging and HLS significantly 
increased the activity of CuZnSOD in gastrocnemius muscles, but this was not affected 
by resveratrol. CuZnSOD activity was significantly increased in gastrocnemius muscles 
from old animals compared to gastrocnemius muscles from young animals (0.083 ± 
.007 vs. 0.055 ± 0.002 U/ml/mg; p ≤ 0.05), resveratrol administration did not alter 
CuZnSOD further with aging (Figure 2A). HLS increased CuZnSOD activity in 
gastrocnemius muscles from both young and old animals regardless of resveratrol 
administration. There was no change in CuZnSOD protein content in the gastrocnemius 
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muscle from any treatment, or age group (Figure 2B). Resveratrol increased CuZnSOD 
activity (Figure 2A) but not CuZnSOD content (Figure 2B) in control muscles from old 
animals. 
 
Refer to Figure 2 
 
MnSOD Enzyme Activity and Protein Content.  MnSOD activity was increased by 
aging and resveratrol in control muscles of old animals. While HLS decreased MnSOD 
activity, MnSOD activity in resveratrol-treated muscles after HLS was elevated over the 
control muscles of old rats. Relative to young animals, MnSOD activity was 78% greater 
(p ≤ 0.05) in vehicle control old animals and resveratrol administration further increased 
MnSOD activity in old non-suspended animals by an additional ~20% (p ≤ 0.05),  
(Figure 2C). HLS had no effect on MnSOD activity in young animals; however, HLS 
significantly reduced MnSOD activity in old vehicle control animals by approximately 
23% (20.3 ± 1.7 vs. 14.6 ± 0.98 U/ml/mg, p ≤ 0.05), resveratrol administration was able 
to completely abolish the decrease in activity seen with HLS. There was no aging effect 
on MnSOD protein content in non-suspended animals, however, similar to activity 
levels, MnSOD protein content was significantly reduced in old suspended animals 
(Figure 2D). Furthermore, resveratrol administration mitigated the effects of HLS on 
MnSOD protein content. 
 
Catalase Activity and Protein Content.  Resveratrol increased catalase activity in 
control muscles of old rats. Catalase activity significantly increased with aging in 
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gastrocnemius muscles from both vehicle control animals and animals that were 
administered resveratrol (p ≤ 0.05) as compared to young adult animals (Figure 2E). 
Furthermore, gastrocnemius muscles from old non-HLS animals who received 
resveratrol had higher catalase activity than old non-HLS vehicle controls (6.14 ± 0.61 
vs. 8.56 ± 0.81 mU activity /mg protein, p ≤ 0.05). HLS had no significant effect on 
catalase activity in either age group, and resveratrol administration showed no further 
increase in catalase activity following HLS. Catalase protein content increased with HLS 
in both young and old animals (Figure  2F). Resveratrol further augmented catalase 
protein abundance in young HLS animals and old non-suspended animals. 
 
Hydrogen Peroxide (H2O2) Concentrations.   H2O2 was assessed in gastrocnemius 
muscle homogenates as an indicator of oxidant load during aging and HLS. Aging and 
HLS increased H2O2 levels in gastrocnemius muscles of old rats, but resveratrol 
suppressed this increase in H2O2 content.  H2O2 levels were ~3 fold higher (p ≤ 0.05) in 
gastrocnemius muscles from old animals when compared to gastrocnemius muscles 
from young animals (Figure 3A). There was a significant interaction of age and 
suspension, (p ≤ 0.05). HLS had no significant effect on H2O2 content in young 
gastrocnemius muscles, regardless of resveratrol administration. Resveratrol 
administration significantly (p ≤ 0.05) reduced H2O2 levels in gastrocnemius muscles 
from old control animals and old-HLS animals by 23% and 16% respectively, when 
compared to gastrocnemius muscles from old vehicle control  and old vehicle control-
HLS animals, (p ≤ 0.05). There was still a significant increase in H2O2 content following 
HLS in gastrocnemius muscles from both vehicle control (2.29 ± 0.06 vs. 2.55 ± 0.05 
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μmols H2O2 /μg protein; p ≤ 0.05) and resveratrol administered animals (1.77 ± 0.16 vs. 
2.14 ± 0.06μmols H2O2 /μg protein; p ≤ 0.05), however there was no difference in the 
H2O2 content between gastrocnemius muscles from old vehicle control and old 
resveratrol-HLS animals (2.29 ± 0.06 vs. 2.14 ± 0.05μmols H2O2 /μg protein). 
 
Refer to Figure 3 
 
Lipid Peroxidation.  Malondialdehyde (MDA) and 4-hydroxyalkenals (HAE) were 
assessed in whole muscle homogenates as indicators of oxidative damage, specifically 
as markers of muscle lipid peroxidation. Both aging and HLS increased lipid 
peroxidation in the gastrocnemius muscle, but this was suppressed by resveratrol.  HLS 
significantly increased lipid peroxidation by ~55 % (p ≤ 0.05)  in young animals 
regardless of resveratrol administration (Figure 3B). Lipid peroxidation was increased in 
old animals compare to their young counterparts (0.171 ± .02 vs.  0.079 ± 0.01 µM 
[MDA/HAE]/mg protein; p ≤ 0.05). There was no further significant increase in MDA and 
HAE levels in old animals that underwent HLS; however, gastrocnemius muscles from 
old animals that were administered resveratrol had significantly reduced levels of lipid 
peroxidation compare to old vehicle control suspended animals (0.199 ± 0.02 vs. 0.159 
± 0.01 µM [MDA/HAE]/mg protein; p ≤ 0.05), this represented a 20% decrease in MDA 





Bax and Bcl-2 Protein Contents.  Aging was generally associated with increased pro-
apoptotic protein signaling in the gastrocnemius muscle. The pro-apoptotic Bax protein 
levels in gastrocnemius muscles from old animals increased ~1.8 fold (p ≤ 0.05), 
regardless of resveratrol administration (Figure 4A). There was no further effect of HLS, 
or resveratrol administration, in either age group. Similarly, Bcl-2 protein levels 
increased 2.6 fold (p ≤ 0.05)  in gastrocnemius muscles from old vehicle control animals 
when compared to their young counterparts (Figure 2B). Resveratrol administration 
further increased Bcl-2 protein content in gastrocnemius muscles from old resveratrol 
non-HLS animals by ~20% (p ≤ 0.05), when compared to gastrocnemius muscles from 
non-HLS vehicle control animals.  HLS significantly increased Bcl-2 protein content in 
gastrocnemius muscles from old vehicle control-HLS animals by ~18.6% (p ≤ 0.05), 
when compared to gastrocnemius muscles from non-HLS vehicle control rats. There 
was no effect of HLS on Bcl-2 content in gastrocnemius muscles from old animals. HLS 
caused significant increases in Bcl-2 protein content in gastrocnemius muscles from 
both young vehicle control (36%, p ≤ 0.05) and young resveratrol administered (29%, p 
≤ 0.05) animals. There was no effect of resveratrol administration in gastrocnemius 
muscles from young animals. 
 
Refer to Figure 4 
 
Caspase 9 and Caspase 3 Activities.  Caspase 9 and 3 activities were measured via 
fluorometric assays as an assessment of the contribution of mitochondrial mediated 
caspase dependent apoptotic signaling. Resveratrol blunted only the aging and HLS-
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induced increase in caspase-9 activity in muscles of old rats.  Both caspase 9 (Figure 
4C) and caspase 3 (Figure 4D) activities were increased in gastrocnemius muscles from 
old animals, when compared to their young counterparts.  Neither caspase 9  nor 
caspase 3 were altered by HLS, or resveratrol administration, in the muscles of  young 
animals.  There was no effect of resveratrol administration on caspase 9 activity in old-
HLS animals, however, resveratrol administration significantly reduced caspase 9 
activity in gastrocnemius muscles from old non-HLS animals (p ≤ 0.05), eliminating the 
aging effect (Figure 4C).  HLS significantly (p ≤ 0.05) increased caspase 3 activity, in 
gastrocnemius muscles from vehicle control-HLS animals; this increase was 
significantly (p ≤ 0.05) attenuated by resveratrol administration. 
 
DNA fragmentation.  A cell death ELISA was used as an indicator of DNA 
fragmentation and the data are presented as an apoptotic index. The apoptotic index 
was increased by aging and HLS in rat gastrocnemius muscles, but resveratrol failed to 
attenuate this increase. Old animals exhibited a 200% increase (p ≤ 0.05) in DNA 
fragmentation regardless of resveratrol administration (Figure 4E). Similarly, 
gastrocnemius muscles from both young and old HLS animals treated with, or without, 
resveratrol, has significantly increased levels of fragmented DNA indicating greater 
levels of apoptosis. HLS increased the apoptotic index by ~5 fold (p ≤ 0.05) in young 
animals and ~3 fold (p ≤ 0.05) in old animals respectively. Resveratrol had no effect on 




Gastrocnemius Muscle Wet Weight.  Resveratrol attenuated the HLS-induced atrophy 
of old rats. Gastrocnemius muscles from young animals were significantly heavier than 
their older counterparts (2.28 ±  0.15g vs.1.55 ± 0.06g; p ≤ 0.05) (Figure 5A). HLS 
elicited significant atrophy in the gastrocnemius muscles from young and old rats. 
Gastrocnemius muscles from young HLS animals weighed on average 28.3% (p ≤ 0.05) 
less than gastrocnemius muscles from young ambulatory control animals. Similarly, 
gastrocnemius muscles from old-HLS animals weighed 26.1%  (p ≤ 0.05) less than 
gastrocnemius from old non-HLS animals. Resveratrol administration had no effect on 
the muscle wet weight of gastrocnemius muscles from young animals following HLS 
(1.62 ± 0.12g vs.1.65 ±  0.11g) (Figure 5A). Gastrocnemius muscle wet weight from old 
vehicle control suspended animals (1.09 ±.09g) was 14.2% less than muscle wet weight 
in old resveratrol-treated suspended animals (1.28 ± 0.07g). Although, this difference 
did not quite reach statistical significance (p = 0.062), it reflects a potential for 
resveratrol to protect against muscle loss in old animals.  There were losses of both 
body weight and muscle weight with HLS in old animals. To determine if resveratrol 
provided a muscle specific but not a body weight specific effect, muscle weight was 
normalized to the animal’s body weight. When muscle wet weight was normalized to 
body weight, resveratrol administration significantly attenuated the relative proportion of 
gastrocnemius muscle lost during HLS in old animals (2.21 ± 0.11mg/g vs. 2.80 ± 
0.21mg/g; p ≤ 0.05) (Figure 5B). This preservation of relative muscle mass, but not body 
weight following HLS was not seen in young animals that were administered resveratrol.  
 




Muscle Functional Measurements.  The HLS-induced force loss was markedly 
attenuated by resveratrol in old animals.  Three in vivo maximal isometric contractions 
were averaged to obtain the pre-HLS force record. This was repeated after HLS to 
obtain the post–HLS force data. The percent decrease of in vivo isometric  force was 
determined by comparing the pre-HLS to post-HLS force records. Maximal isometric 
measurements were obtained on age-matched ambulatory rats at the two time points 
that corresponded to the pre-HLS and post-HLS measures in the experimental animals. 
Maximal plantar flexor force did not change over the duration of the study period for 
either young adult or old ambulatory rats (data not shown). Young animals lost an 
average of 33.7% of their maximal isometric force following HLS, and resveratrol 
administration did not attenuate the force loss in these animals (32.09 ± 9.79% vs. 
35.37 ± 7.74%)(Figure 5C). However, resveratrol administration significantly preserved 
isometric force output following HLS in old animals, (45.9 ± 6.8% vs. 31.6 ± 7.4%; p ≤ 
0.05) (Figure 5C).  To determine if muscle force was preferentially maintained during 
weight loss, we normalized isometric force to the animal’s body weight (Figure 5D). 
When the percent decrease in isometric force following HLS was normalized to body 
weight, old vehicle control-HLS  animals lost a significantly larger (p ≤ 0.05)  proportion 
of isometric force output than did their young counterparts, (Figure 5D). This aging 





Oxidative stress is positively correlated with skeletal muscle atrophy induced by 
aging (27), denervation (45), disuse (22) and immobilization (45). These atrophic stimuli 
are associated with concomitant increases in lipid peroxidation (47), glutathione 
oxidation (47), protein carbonyl formation (44) and myonuclear apoptosis (12). 
Furthermore, oxidative stress is linked to proteolytic processes that mediate muscle loss 
through caspase 3 activation (45). Although skeletal muscle disuse induces oxidative 
stress in both young and old animals (6,28), skeletal muscle from older animals 
possesses a higher basal level of oxidative stress placing more strain on the 
endogenous antioxidant system, and thus leaving skeletal muscle from these animals at 
greater risk for oxidative damage during periods of disuse, and subsequent diminished 
recovery following disuse. 
The current investigation sought to shed light on the mechanisms underlying 
muscle atrophy with disuse and to ascertain if oxidative stress and/or apoptosis were 
possible contributing factors. Furthermore, the present study sought to elucidate the 
potential role of resveratrol administration to alleviate oxidative stress and apoptosis in 
skeletal muscle from old and young animals. Dietary supplementation with the 
polyphenol, resveratrol, has the potential to exert beneficial effects not only through its’ 
ability to directly scavenge free radicals (36,39) and upregulate components of the 
endogenous antioxidant system  (34), but also by its’ capacity to modulate the signal 
transduction and gene expression of several pathways regulating cellular proliferation 
(20,53), mitochondrial biogenesis  (50,53), metabolism (41),  and apoptosis (20). The 
efficacy of acute resveratrol administration has been established for several 
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pathological conditions (35,36,39); however, this study provides the first insight into the 
use of resveratrol supplementation as a counter-measure to combat muscle loss and 
function caused by disuse. 
Hindlimb suspension resulted in a significant loss of gastrocnemius muscle mass 
as estimated from muscle wet weight (Figure 5A).  Although there was no significant 
preservation of gastrocnemius muscle mass resulting from resveratrol administration, 
there was a significant preservation of the relative ratio of muscle mass preserved 
normalized to animal body weight in old HLS animals (Figure 5B). This protective effect 
may suggest a preferential preservation of skeletal muscle tissue with resveratrol 
administration in old animals following a prolonged period of disuse, since there was no 
difference in the total percentage of body mass lost between old resveratrol 
supplemented and old non-supplemented animals during the experimental period 
(Table1).  Likewise, in old, but not young animals, there was a partial maintenance of 
maximal isometric force of the plantar flexor muscle group following HLS. The percent 
decrease in isometric force following HLS in old resveratrol administered animals was 
similar to the force decrements seen in the plantar flexors of young animals following 
HLS, thus eliminating the interaction of age and suspension. The findings showing a 
protective effect of resveratrol on force production in the current study, are consistent 
with data from Lagouge and colleagues (23), showing greater muscle strength in mice 
fed a high fat diet supplemented with resveratrol. 
In general, the in vivo isometric force output that was measured in the current 
study, is the sum of forces that were generated by all of the individual muscles 
comprising the plantar flexor group. The plantar flexor muscle group consists of the 
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soleus, plantaris and gastrocnemius muscles which, contribute approximately 6%, 16% 
and 78% respectively,  to the mass of the rat plantar flexor muscles (11,51). As a result, 
the gastrocnemius muscle provides the greatest contribution to plantar flexion force 
output, and thus, the partial preservation of relative gastrocnemius muscle wet weight 
and plantar flexion force production are likely linearly related. 
Resveratrol administration mediated endogenous antioxidant enzymes and 
oxidative stress indices in old animals. Specifically, resveratrol administration 
significantly increased MnSOD activity and protein content, but not CuZnSOD activity in 
old HLS animals (Figure 2). This is analogous with data showing that resveratrol 
protected against oxidative stress through the specific induction of MnSOD (39). 
Additionally, in the current study, resveratrol administration increased the content and 
activity of catalase in old non-suspended animals, but it did not further increase catalase 
activity, or expression following HLS. This may be in part because catalase activity is 
already increased with aging and HLS, so it may have reached a maximal point of 
induction. Perhaps most importantly, resveratrol administration reduced indices of 
oxidative stress in gastrocnemius muscles of old HLS animals, as estimated by H2O2 
levels and the lipid peroxidation byproducts (MDA and HAE). This is congruent with 
recent data from our laboratory and others that have shown that resveratrol protects 
against  H2O2  mitigated lipid peroxidation in vivo (39,41) and in vitro (4). The induction 
of catalase by resveratrol has previously been demonstrated  (39), and along with 
increases in MnSOD, may represent important mechanisms by which resveratrol acts to 
reduce H2O2 and H2O2-mediated damage. However, these protective effects of 
increases in antioxidant enzyme activity and concomitant decreases in markers of 
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oxidant load were not seen in young animals administered resveratrol, suggesting that 
there is a differential effect of resveratrol in young and old animals. The fact that 
resveratrol only seems to have an effect in old animals is interesting and is plausibly 
due to different underlying signaling mechanisms that may occur in old animals during 
disuse.  It is also possible that younger animals are able to handle the stress of hindlimb 
suspension and the subsequent detrimental effects that are associated with skeletal 
muscle disuse and therefore the pre-conditioning effect of resveratrol administration 
helps to augment the stress response in old, but not young animals where it is not 
needed. This is congruent with our finding that H2O2 concentrations were not increased 
in young animals following suspension. Although, lipid peroxidation markers were 
increased in muscles from young suspended animals, despite no increases in H2O2 
concentrations, this might indicate a temporal role of oxidative stress in young animals 
during muscle disuse. 
Oxidative stress is upstream of apoptotic signaling in muscle cells in vitro (46) 
and results in the initiation of the intrinsic mitochondrial apoptotic pathway.  Due to its 
multi-nucleated cellular structure, skeletal muscle is an exception to the linear 
relationship between apoptosis and cell death.  Instead, apoptosis in skeletal muscle 
results in a loss of myonuclei and consequent fiber atrophy (3). Myonuclei undergo 
apoptosis in many muscle wasting conditions including, but not limited to, advanced age 
(31), disuse (42,44) and denervation (1,43). Likewise, these conditions are also 
associated with increases in oxidative stress (1,27) presumably mediated through 
mitochondrial dysfunction, given the importance that the mitochondria play in 
70 
 
maintaining cellular integrity via ROS production and the regulation of the apoptotic 
pathway (2,17,44). 
Resveratrol administration altered apoptotic signaling (e.g., Bcl-2, caspase 9 
activity) but it did not appear to blunt overall myonuclear apoptosis in muscles from old 
animals. Resveratrol administration increased the protein content of  the anti-apoptotic 
protein Bcl-2 in old non-HLS animals suggesting a preconditioning effect by which 
resveratrol could potentially improve the apoptotic environment of skeletal muscle 
undergoing disuse. Our data are in agreement with a study by Brito and colleagues 
(12), suggesting that resveratrol was able to protect against oxidant-induced apoptotic 
signaling through the upregulation of Bcl-2, without any reductions of Bax protein 
content. Downstream of the mitochondrial mediated apoptotic signaling cascade are the 
proteolytic caspase enzymes. Resveratrol administration significantly decreased 
caspase 9 activity in old non-HLS animals and significantly decreased caspase 3 
activity in old HLS animals. In parallel with the other findings from the current study, 
caspase activity was only attenuated in the gastrocnemius muscles from old animals, 
with no effect being seen in muscles from the young animals. 
Interestingly, the alleviation of oxidative stress and damage in old HLS animals 
administered resveratrol did not translate into protection from apoptosis as estimated 
from the quantity of DNA fragmentation present following HLS. This suggests that the 
protective effect of resveratrol may be in part to its anti-inflammatory and/or anti-
proteolytic capacities rather than anti-apoptotic capabilities. This would be in agreement 
with the fact that resveratrol was able to decrease caspase 3 following HLS in old 
animals, despite having no efficacy in ameliorating apoptosis following HLS. Caspase 3 
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is known to be redox sensitive and to play an initiating role in muscle proteolysis via the 
ubiquitin-proteasome system (20). Although it is not known why a significant increase in 
Bcl-2 protein content did not confer resistance to apoptosis following HLS, it could be 
speculated that the relative contribution of apoptosis versus necrosis and other 
mechanisms of disuse mediated atrophy are temporal in nature. Since data in our study 
were only collected at one time point (14 days), it is possible that early protection 
against apoptosis was not detected, but it still may have contributed to the preservation 
of muscle mass and maintenance of isometric force seen in old animals administered 
resveratrol. 
It is also probable, (although not evaluated in this study), that the protective 
effects of resveratrol observed in the current investigation stem from the ability of 
resveratrol to activate the silent mating type information regulation 2 homolog (Sirt1), a 
NAD+ dependent histone deacetylase (20). Sirt1 has been shown to play a role in a 
variety of important physiological functions including the regulation of oxidative stress.  
Congruent with our current observations regarding resveratrol administration, Sirt1 
activation is reported to upregulate the transcription of both MnSOD (48) and catalase 
(15,16) and reduce reactive oxygen species-induced apoptosis (15).  This highlights the 
potential of Sirt1 to act as a protective mechanism against oxidative stress. The wide 
range of Sirt1’s cell signaling capacity underscores the potential ability of resveratrol to 
mediate a variety of cell signaling pathways and therefore provides many potential 
therapeutic targets that may be responsible for the attenuation of skeletal muscle 
atrophy and force preservation observed during disuse in old animals. Gaining clearer 
insight into the molecular signaling pathways involved in aging and disuse muscle 
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atrophy is paramount in developing nutritional and/or pharmacological interventions to 
minimize protein loss and attenuate the functional decrements associated with atrophic 
conditions. 
In summary, the results of the current study show that resveratrol treatment 
reduces the functional decrements and the oxidative stress levels in rat hindlimb 
muscles in response to disuse.  One potential mechanism for improved muscle function 
in resveratrol treated animals is via a Sirt1 mediated improvement in the endogenous 
antioxidant enzyme activity and the redox status of the aging muscle during disuse. 
However, it is also possible that the protective effects of resveratrol are unrelated to 
Sirt1 or blunting oxidative stress. For example, administration of resveratrol has been 
shown to attenuate protein degradation in murine myotubes treated with proteolysis-
inducing factor, enhanced the proliferation of muscle precursor cells (34),  and blunted 
muscle weight loss, and  protein degradation, in vivo, in a mouse model of cachexia 
(52). Additional studies are needed to determine if resveratrol activation of Sirt1 has the 
potential to be an effective therapeutic intervention, by reducing ROS, or if resveratrol 
functions via another mechanism, to lower the extent of loss of muscle mass or function 
in aged humans, in response to reduced activity or bed rest. 
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Table 2.1 Animal Body Weight. Animals were weighed pre and post-hindlimb 
suspension (HLS). Body weights (BW) are represented in grams (g) and 
as percent changes (%Δ) in body weights during the 21 day the 
experimental protocol. YVC = Young Vehicle Control, YVCS = Young 
Vehicle Control Suspended, YRC = Young Resveratrol Control, YRS = 
Young Resveratrol Suspended, OVC = Old Vehicle Control, OVCS = Old 
Vehicle Control Suspended, ORC = Old Resveratrol Control, ORS = Old 
Resveratrol Suspended. **Denotes significantly difference (p ≤ 0.05) 
between non-suspended treatment matched control (Suspension effect). # 
















Figure 2.1  Experimental protocol. Resveratrol was administered via oral gavage at 
a dose of 12.5 mg/kg/day for 21 days. One milliliter of 0.01% 
carboxymethylcellulose was used as a vehicle control.  Following 7 days 
of resveratrol administration animals were randomly assigned to 14 days 
of hindlimb suspension (HLS), or continued ambulation. Following the 
experimental protocol, the gastrocnemius muscles were dissected and 
assessed for muscle wet weight, oxidative stress, and apoptotic indices. 
MWW, muscle wet weight. 
Figure 2.2 Enzymatic activities and protein contents of CuZnSOD, MnSOD and 
catalase in response to aging and HLS (A) CuZnSOD activity was 
assessed using a spectrophotometric assay and is expressed as units of 
enzymatic activity (U)/mL/mg protein. (B) CuZnSOD protein content was 
determined via immunoblotting; a representative blot is shown. (C) 
MnSOD activity was assessed using a spectrophotometric assay and is 
expressed as units of enzymatic activity (U)/mL/mg protein. (D) MnSOD 
protein content was determined via immunoblotting; a representative blot 
is shown. (E) Catalase activity was assessed using a spectrophotometric 
assay and is expressed as milliunits of enzymatic activity (mU)/mg protein. 
(F) Catalase protein content was determined via immunoblotting; a 
representative blot is shown. YC= Young Control, YS = Young 
Suspended, OC = Old Control, OS = Old Suspended, YVC = Young 
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Vehicle Control, YVCS = Young Vehicle Control Suspended, YRC = 
Young Resveratrol Control, YRS = Young Resveratrol Suspended , OVC 
= Old Vehicle Control, OVCS = Old Vehicle Control Suspended, ORC = 
Old Resveratrol Control, ORS = Old Resveratrol Suspended.** p ≤ 0.05, 
non-suspended treatment vs. matched control (Suspension effect). # p ≤ 
0.05, young treatment matched (Aging effect). * p ≤ 0.05, vehicle control 
vs. age-matched and treatment matched group (Effect of resveratrol). 
 
Figure 2.3 Resveratrol attenuated increases in hydrogen peroxide (H2O2) 
concentration and lipid peroxidation associated with HLS in old 
animals.  (A) H2O2 concentrations were determined fluorometrically in 
gastrocnemius muscle homogenate. Data are expressed as 
µmols/H2O2/µg protein. Significance was set at (p ≤ 0.05) and all data are 
represented as mean ± standard error. (B) MDA and HAE levels were 
evaluated as a combined marker of lipid peroxidation and expressed in 
µM[MDA/HAE]/mg protein.  YC= Young Control, YS = Young Suspended, 
OC = Old Control, OS = Old Suspended, YVC = Young Vehicle Control, 
YVCS = Young Vehicle Control Suspended, YRC = Young Resveratrol 
Control, YRS = Young Resveratrol Suspended, OVC = Old Vehicle 
Control, OVCS = Old Vehicle Control Suspended, ORC = Old Resveratrol 
Control, ORS = Old Resveratrol Suspended. **  p ≤ 0.05, non-suspended 
control vs. suspended animals (Suspension effect). # p ≤ 0.05, old vs. 
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young treatment matched (Aging effect). * p ≤ 0.05, vehicle control vs.  
age-matched and treatment matched groups (Effect of resveratrol). 
 
Figure 2.4 The effects of resveratrol administration and HLS on apoptotic 
signaling in young and old animals. (A) Bax protein content was 
determined via immunoblotting; a representative blot is shown (B) Bcl-2 
protein content was determined via immunoblotting; a representative blot 
is shown (C) Caspase 9 Activity was assessed using a fluorometric assay 
(D) Caspase 3 Activity was assessed using a fluorometric assay (E) Cell 
Death ELISA YC= Young Control, YS = Young Suspended, OC = Old 
Control, OS = Old Suspended, YVC = Young Vehicle Control, YVCS = 
Young Vehicle Control Suspended, YRC = Young Resveratrol Control, 
YRS = Young Resveratrol Suspended, OVC = Old Vehicle Control, OVCS 
= Old Vehicle Control Suspended, ORC = Old Resveratrol Control, ORS = 
Old Resveratrol Suspended. **p ≤ 0.05, non-suspended control vs. 
suspended animals (Suspension effect). # p ≤ 0.05, old vs. young 
treatment matched (Aging effect). *p ≤ 0.05, vehicle control vs.  age-
matched and treatment matched groups (Effect of resveratrol). 
 
Figure 2.5   Gastrocnemius muscle wet weight and plantar flexor maximal 
isometric force. The gastrocnemius muscles were dissected, 
immediately blotted and weighed as a gross estimation of muscle size and 
represented in grams (g, A), or as ratio to the animal’s body weight (mg/g, 
77 
 
B). Pre and post-HLS force measurements were assessed. Three 
isometric contractions were recorded per animal for both pre and post–
HLS assessments. The average of the three contractions at each time 
point was used to determine the decrease in isometric force output 
following HLS. The average force decrease with HLS (C) or the decrease 
in force normalized to body weight (D) demonstrates that resveratrol 
preserved loss of function in hindlimb muscles of the old rats. Significance 
was set at (p ≤ 0.05) and all data are represented as mean ± standard 
error. YC= Young Control, YS = Young Suspended, OC = Old Control, OS 
= Old Suspended, YVC = Young Vehicle Control, YVCS = Young Vehicle 
Control Suspended, YRC = Young Resveratrol Control, YRS = Young 
Resveratrol Suspended, OVC = Old Vehicle Control, OVCS = Old Vehicle 
Control Suspended, ORC = Old Resveratrol Control, ORS = Old 
Resveratrol Suspended. **p ≤ 0.05, non-suspended control vs. suspended 
animals (Suspension effect). # p ≤ 0.05, old vs. young treatment matched 
(Aging effect). *p ≤ 0.05, vehicle control vs.  age-matched and treatment 
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Figure 2.2: Enzymatic activities and protein contents of CuZnSOD, MnSOD and          





Figure 2.3: Resveratrol attenuated increases in hydrogen peroxide (H2O2) 






Figure 2.4: The effects of resveratrol administration and HLS on apoptotic signaling in 
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This study analyzed the capacity of resveratrol, a naturally occurring polyphenol, to 
reduce aging-induced oxidative stress, and protect against sarcopenia.  Middle-aged 
(18mo) C57/Bl6 mice were randomly assigned to receive either a control diet or a diet 
supplemented with 0.05% trans-resveratrol for 10 months. Young (6mo) and middle-
aged (18mo) mice were used as controls. Resveratrol supplementation did not reduce 
the aging-associated loss of muscle mass or improve maximal isometric force 
production, but it appeared to preserve fast-twitch fiber contractile function. Resveratrol 
supplementation did not improve mitochondrial content, the subcellular localization of 
cytochrome c protein content, or PGC1 protein content. Resveratrol increased MnSOD, 
reduced H2O2, and lipid peroxidation levels in muscle samples, but it was unable to 
significantly reduce protein carbonyl levels.  The data suggest that resveratrol has a 
protective effect against aging-induced oxidative stress in skeletal muscle, likely through 
the upregulation of MnSOD activity, but sarcopenia was not attenuated by resveratrol. 
 









Advanced age leads to a loss of muscle mass and function, termed sarcopenia 
(64). The causative factors of sarcopenia are multifactoral, and include a progressive 
denervation of muscle fibers (21), an altered hormonal milieu (75), and a net loss of 
contractile proteins, (37; 57).  While no causal relationship has been established, 
skeletal muscle atrophy is often associated with an increased production of reactive 
oxygen species (ROS), (48; 49; 56), leading to an amplified oxidant-load.  An increase 
in oxidant exposure, in conjunction with the less effective endogenous anti-oxidant 
systems often present in aged animals (54; 58) can lead to oxidative stress. Chronic 
oxidative stress left unchecked over time leads to the oxidation, and thus damage, of 
cellular macromolecules, including lipids (53), nucleic acids (29) and proteins (11; 20; 
30). This progressive and cyclical oxidative assault on cellular macromolecules is 
believed to be an important contributor to the aging process (25) and is thought to be 
responsible for many of the pathologies associated with aging, including genomic 
instability, mitochondrial dysfunction and chronic inflammation (25; 26), all of which are 
associated with sarcopenia (13). 
Supplementation with the naturally occurring phytoalexin, resveratrol (3,4',5-
trihydroxystilbene), has recently been shown to protect against oxidative stress in 
rodent skeletal muscle (32; 67)  and to act as a systemic anti-inflammatory agent in vivo 
(24). Specifically, in skeletal muscle, resveratrol has been shown to upregulate 
components of the endogenous antioxidant system (32; 67), reduced the oxidant load 
within the muscle environment and consequently attenuate oxidative damage 
associated with muscle loading (67), unloading (32) and aging (32; 67).  Furthermore, 
resveratrol administration was able to significantly mitigate muscle atrophy in a mouse 
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model of cachexia (80). Resveratrols’ ability to directly scavenge free radicals resides in 
its phenol ring and resveratrol has repeatedly been shown to be a potent scavenger of 
reactive oxygen species (ROS) in numerous cell types exposed to oxidants (12; 36; 47; 
62).  However, its rapid first pass metabolism in mammals and thus relatively low 
bioavailability (19; 23; 46), may limit its role as a direct ROS scavenger in vivo. 
Consequently, in vivo, resveratrols’ various health benefits can more likely be attributed 
to its ability to activate the NAD+ dependent deacetylase, silent mating type information 
regulation homolog1, or sirtuin1 (Sirt1) (2; 40).  
Sirt1 has been shown to play a role in a variety of important physiological 
functions including inflammation (24), mitochondrial biogenesis (40) and the regulation 
of oxidative stress and anti-oxidant enzymes (27; 39)  in a wide array of cell types (38; 
40; 51; 78). Sirt1 is also activated with exercise (74) and under conditions of nutrient 
deprivation (14; 79), underscoring resveratrols effectiveness as a caloric restriction 
mimetic. These conditions in which Sirt1 activation is elicited are significant because 
both exercise (71; 73) and caloric restriction (7; 14; 41)  are proven countermeasures to 
combat both oxidative stress and sarcopenia.  Furthermore, Sirt1 is a powerful positive 
mediator of PPARγ co-activator (PGC-1α) (76), which is considered to be the master 
regulator of mitochondrial function and biogenesis (43).  PGC-1α is decreased during 
atrophic conditions (68; 69) and muscle specific over expression of PGC-1α confers 
protection against both denervation and fasting-induced skeletal muscle atrophy (69).  
Increases in PGC1 signaling have the potential to alleviate age-related mitochondrial 
alterations which underlie a wide variety of diseases such as diabetes (45), 
neurodegeneration (70) and sarcopenia (13).  
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Although mitochondria are not the sole source of ROS within a cell, they are 
routinely viewed as the principle site of superoxide generation, which is the primary 
source of damaging ROS within muscle cells (33; 34). Resveratrol’s ability to increase 
PGC1 signaling, via Sirt1 activation, could potentially provide a two-fold mechanism with 
which to protect aged skeletal muscle against oxidative stress. Firstly, resveratrol has 
been shown to act as a direct and indirect anti-oxidant diminishing the likelihood of 
phospholipid oxidation and thus damage within the mitochondrial membrane preserving 
the integrity of the membranes and thus preventing “leaky” mitochondria. In addition, 
resveratrol has been shown to promote mitochondrial biogenesis in skeletal muscle in a 
Sirt1 dependent fashion (40) thus potentiating the possibility to replace damaged 
mitochondria in aged animals.  
Acute resveratrol administration has been recently shown to reduce oxidative 
stress and improve functional outcomes in rodent skeletal muscle (32; 67); however, the 
efficacy of chronic resveratrol supplementation as a counter-measure to combat 
sarcopenia has not been established. Thus, the purpose of the current investigation was 
to determine if long-term dietary supplementation, from middle-age through 
senescence, with moderate doses of resveratrol would effectively attenuate the loss of 
muscle mass and function that occurs in aged animals. It was hypothesized that 
resveratrol’s ability to activate Sirt1 would consequently enhance the endogenous anti-
oxidant system and increase PGC1 signaling, thereby reducing the release of ROS from 
mitochondrion. Furthermore, it was hypothesized that resveratrol supplementation 
would maintain muscle function in aged animals both by preservation of muscle mass 
and by providing a more favorable redox environment  
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Methods        
 
Experimental Protocol.  Experiments were conducted on young adult (3 mo), middle-
aged (18 mo) and aged (28 mo) C57BL/6 mice obtained from the National Institute on 
Aging colony (Harlan, Indianapolis, IN). The mice were housed in pathogen-free 
conditions at ~20oC. All mice had free access to food and water. Middle-aged mice were 
put on either a control diet of normal mouse chow, (AIN-76A Rodent Diet, Research 
Diets Inc, New Brunswick, NJ), or an identical diet containing 0.05% resveratrol 
(Research Diets Inc, New Brunswick, NJ). Resveratrol was purchased from Orchid 
Pharmaceuticals (India).  Mice of 3 mo and 18 mo of age were used as control animals 
only. Aged animals were sacrificed at 28 months after 10 months of being on either the 
control, or resveratrol-supplemented diet. Immediately following sacrifice, skeletal 
muscles were dissected for use in either biochemical analyses, mitochondrial isolation 
and/or physiological analyses. All experimental procedures carried approval from the 
Institutional Animal Use and Care Committee from West Virginia University School of 
Medicine.  
 
Ex vitro muscle physiological analysis. Isometric muscle contractile properties were 
examined in the plantaris muscles of control and resveratrol-treated mice. The muscles 
were placed in an oxygenated ringers solution (in mM: 137 mM NaCl, 4.7mM KCl, 
3.4mM CaCl2, 1.2mM MgSO4  1 NaH2PO4, and 112 D-glucose). The Ringer solution 
was aerated with 95% O2 and 5% CO, (pH 7.4). The temperature of the solution was 
kept at 20°C. The distal end of the muscle was attached to a stationary plexiglass plate, 
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and the proximal end was fixed to the lever arm of a 300C dynamometer (Aurora 
Scientific, Aurora Ontario, Canada). The muscles were stimulated by passing a constant 
current through platinum plates that were positioned on either side of the muscle.   Ex 
vivo isometric twitch and tetanic contractions were obtained using a Constant 
Current/Constant Voltage Stimulator (Aurora Scientific) that provided DC-square wave 
signals at stimulation current of 12 Volts, with a 200 µs pulse width. Muscles were 
adjusted to the optimal muscle length (Lo) by a micromanipulator that controlled the 
base position of the electrode clamp. Lo was established as the muscle length that 
produced maximal isometric twitch tension. Lo was periodically checked by the same 
procedure throughout each experiment.  Force-frequency isometric force records were 
obtained by stimulating the muscle at 10, 20, 40, 50, 75 and 100 Hz, with 3 minutes of 
rest between each contraction.  Physiological contractile measures included peak 
isometric twitch force (PT), time to peak twitch contraction tension (CT), ½ relaxation 
time of twitch contraction (½ RT), and peak isometric tetanic force (Po), as previously 
described  (3; 4).  Following isometric contractions, the muscles remained in 
oxygenated Ringers for 5 minutes prior to the repeated stimulation fatigue protocol. 
Muscle fatigue was assessed by stimulating the muscle at 40Hz for 3 minutes with a 
duty cycle of  330 ms of stimulation followed by 660 ms of rest (15).  The fatigue index 
was calculated as the difference in force from the average of the first three contractions 
to the average of the final three contractions. The contractile and fatigue measurements 
were analyzed off line using commercial software (DMI, Aurora Scientific). 
Protein Isolation.  Approximately 40 µg of gastrocnemius muscle from each animal 
was homogenized in 500 μL of RIPA buffer (1% Triton x-100, 150mM NaCl, 5mMEDTA, 
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10mM Tris; pH: 7.4) using a mechanical homogenizer, for use in the assessment of 
protein expression via immunoblotting. Muscle homogenates were then centrifuged at 
1000 x g for 5 minutes at 4°C. The resulting supernatant was collected and divided into 
two portions and frozen at –80°C  either with, or without a protease inhibitor cocktail 
containing 104 mM 4-[2-aminoethyl]-benzenesulfonyl fluoride hydrochloride, 0.8 mM 
aprotinin, 2 mM leupeptin, 4 mM bestatin, 1.5 mM pepstatin A, and 1.4 mM E-64 
(Sigma-Aldrich, St. Louis, MO) added to it. 
For all enzyme activity assays, and/or oxidative damage assessments muscle 
samples were homogenized in the appropriate volume of either PBS, or the kit specific 
buffer provide by the manufacturer. Protein concentrations for each sample were 
determined in duplicate using the DC Protein Assay kit (Bio-Rad, Hercules, CA).  
Mitochondrial isolation. The vastus lateralis muscles were carefully removed while the 
mice remained under deep anesthesia (5% isoflurane / 95% oxygen). Precautions were 
made to assure that the blood supply to the muscles remained intact until it was 
removed to prevent the artificial accumulation of oxidants. Mitochondria and 
mitochondria free cytosolic muscle fractions were obtained using a commercially 
available mitochondrial isolation kit specifically designed for animal tissue (MITOISO1-
1KT, Sigma-Aldrich Co., St Louis, MO). The fractions were obtained using sequential 
separation steps involving a protease digestion followed by separation of the fractions 
via centrifugation using slight modifications of the manufacturer’s recommendations. 
Briefly, the gastrocnemius muscle was placed on ice and minced in a 1.5ml eppendorf 
tube. Samples were washed and re-suspended in an extraction buffer containing 0.25 
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mg/ml trypsin. After a 20 minute incubation period, albumin was added to a final 
concentration of 10 mg/ml to quench the proteolytic reaction. Samples were then 
washed and re-suspended in extraction buffer and then gently homogenized with a 
Teflon pestle. The homogenate was then centrifuged at 600 x g for 5 minutes. The 
supernatant was transferred to a new tube and centrifuged at 11,000 x g for 10 minutes 
and transferred to a new tube. The supernatant was centrifuged for 10min at 11,000 x g 
and transferred to a new tube to assure a clean mitochondrial free cytosolic fraction. 
The mitochondrial pellet was suspended in a sucrose storage buffer.  
Manganese Superoxide Dismutase (MnSOD) and Copper-Zinc Superoxide 
Dismutase (CuZnSOD) Enzyme Activity Levels.  Superoxide dismutase activity was 
measured in vastus lateralis muscle homogenate that was partitioned into a 
mitochondrial pellet and mitochondrial-free cytosolic fraction. Enzymatic activity was 
assessed using a colorimetric enzyme activity kit (Cayman Chemical Company Ann 
Arbor, MI) following the manufacturer’s guidelines. CuZnSOD activity was obtained from 
the cytosolic fractions and MnSOD activity was measured using isolated mitochondria. 
All samples and standards were measured in duplicate.  The assay was performed in a 
96-well plate and mitochondrial samples were treated with 10µL of 12 mM potassium 
cyanide to inhibit any residual CuZnSOD activity. The absorbance of the resulting 
colorimetric changes were measured at a wavelength of 450 nm using a 96-well plate 
reader (Dynex Tech., Chantilly VA., USA).  The samples were normalized to the protein 
concentration in each sample as assessed using a DC protein concentration assay (Bio-




Immunoblots. The protein content of CuZnSOD and MnSOD were measured in vastus 
lateralis total muscle homogenate. Cytochrome C protein content was measured in the 
cytosolic (mitochondrial free) fraction of the vastus lateralis muscle, the corresponding 
mitochondrial fractions and total muscle homogenate.  The protein content of Sirt1 and 
PGC-1 were measured in gastrocnemius total muscle homogenates. β-tubulin was used 
as a loading control for cytosolic fractions and total homogenate. A ponceau stain was 
used to validate equal loading of the mitochondrial fraction.  Thirty to forty micrograms of 
protein were loaded into each well of a 4%–12% gradient polyacrylamide gel (Invitrogen, 
Carlsbad, CA) and separated by routine sodium dodecyl sulfate–polyacrylamide gel 
electrophoresis (SDS–PAGE) for approximately 1.5hrs at 20°C, followed by transfer to a 
nitrocellulose membrane for 70-120 min at 35V. All membranes were blocked in 5% 
nonfat milk (NFM) for 1 hour at room temperature.  Membranes were then incubated in 
the appropriate primary antibodies, overnight at 4°C. Primary antibodies were diluted in 
Tris-buffered saline, with 0.1% Tween-20 (TBST) and 10% sodium azide. Membranes 
were then washed in 0.05% TBST followed by incubation in the appropriate dilutions of 
secondary antibodies (diluted in 5% NFM in TBST) conjugated to horseradish 
peroxidase. Signals were developed using a chemiluminescent substrate (Lumigen 
TMA-6; Lumigen, Southfield, MI) and visualized by exposing the membranes to X-ray 
films (BioMax MS-1; Eastman Kodak). Digital records were captured by a Kodak 290 
camera, and protein bands were quantified using 1D analysis software (Eastman 





Sirt1 Activity. Sirt1 activity was measured using components of the Sirt1 Fluorimetric 
Drug Discovery Kit (BIOMOL, Plymouth Meeting, PA # AK -555). In short, endogenous 
Sirt1 activity was measured in total gastrocnemius muscle homogenates homogenized 
in ice-cold PBS (pH =8.0) using the fluorescent deacetylase substrate and developer 
provided in the kit. Following homogenization each sample was quantified using a DC 
protein concentration assay (Bio-Rad, Hercules, CA) and diluted to 2.5 µg/µL using the 
kit supplied assay buffer.  The fluorescent substrate in conjunction with 100 µM of the 
co-substrate NAD+ was incubated with 25 µL of each sample for 30 minutes at RT in a 
½ volume 96 well white microplate. Following this incubation 2mM Nicotinamide (Sirt1 
inhibitor) and the provided fluorescent developer were added to each well to stop the 
reaction and produce a fluorophore that is linearly related to Sirt1 activity. Resveratrol 
and Suramin were combined with the provided recombinant Sirt1 and were used as 
positive and negative controls respectively. Additionally, a mouse liver homogenate was 
used as an additional positive control. The intensity of the fluorescent signal was 
detected using an excitation wavelength of 360 nm and an emission wavelength of 460 
nm. Data are presented as fluorescent units normalized to the milligrams of protein 
present in each homogenate. 
 
Citrate Synthase Activity. Citrate synthase activity was measured in gastrocnemius 
whole tissue extracts using a commercially available kit (CS0720 Sigma-Aldrich, Saint 
Louis, MO). Citrate synthase activity has been extensively used as a marker of 
mitochondrial mass (40; 59)  and is a suitable marker for use in whole muscle 
homogenate given that it’s located in the mitochondrial matrix; the enzyme’s activity 
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would be minimally affected by the homogenization procedure. Muscle samples were 
homogenized in ice-cold CelLytic MT Cell Lysis Reagent (C3228) and the resultant 
homogenate was centrifuged at 12,000 x g for 10 minutes to remove cellular debris. The 
resulting supernatant was used for the kinetic assessment of citrate synthase activity. 
The assay was performed in a 96 well plate as per manufactures instructions. Briefly, 
8µL of each muscle homogenate was added to a master mix containing the supplied 
assay buffer, 30mM Acetyl CoA solution and 10mM DTNB solution. The reaction was 
initiated with the addition of 10µL of oxaloacetic acid and the formation of citric acid was 
determined spectrophotometrically at a wavelength of 412nm at an interval of 
90seoncds for 10minutes.  Net citrate synthase activity was calculated as the 
endogenous citrate synthase activity subtracted from total activity. All analyses were 
measured in duplicate and the samples were normalized to µg of protein per μL of 
muscle homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules, 
CA). 
 
Hydrogen Peroxide (H2O2) Content.  H2O2 content in gastrocnemius muscle 
homogenate was measured using a fluorescent assay according to the manufacturer’s 
recommendations (Cell Technology, Mountain View, CA). Briefly, 50 μL of control, 
unknown muscle samples, or H2O2 standards were mixed with 50 μL of the reaction 
cocktail provided in the kit and added to each well to initiate the reaction. The plate was 
then incubated in the dark for 10 minutes at room temperature. The intensity of the 
fluorescent signal was detected using an excitation wavelength of 530 nm and an 
emission wavelength of 590 nm. A linear regression was performed by plotting the 
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resultant florescent intensities from the known standards and subsequently the 
unknown samples were fit to the corresponding linear equation. All analyses were 
measured in duplicate and the samples were normalized to µg of protein per μL of 
muscle homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules, 
CA). 
Lipid Peroxidation. Malondialdehyde (MDA) and 4-hydroxyalkenals (HAE) were 
measured using the methods and reagents from Oxis International, CA (BIOXYTECH 
LPO-586). Approximately 50 mg of gastrocnemius muscle was homogenized in 750 μL 
of ice cold buffer containing phosphate-buffered saline (20 mM, pH 7.4) and 5 μL of 0.5 
M butylated hydroxytoluene in acetonitrile per 1 mL of tissue homogenate. Assay 
reagents were added following the manufacturer's recommendations and have been 
previously described by our laboratory (66). Briefly, the muscle homogenate was 
centrifuged at 3000 x g at 4°C for 10 minutes, and the supernatant was carefully 
collected and used to quantify lipid peroxidation. The supernatant was subsequently 
incubated in the proper reagents at 45°C for 60 minutes, as per the manufactures 
instructions, and then centrifuged at 15,000 x g for 10 minutes. The absorbance of the 
resulting sample was read at 586 nm. All analyses were measured in duplicate and the 
samples were normalized to µg of protein per μL of total gastrocnemius muscle 
homogenate as determined by the DC Protein Assay Kit (Bio-Rad Hercules, CA). 
Protein Carbonyls.  A colorimetric protein carbonyl assay kit (#10005020 Cayman 
Chemical Company, Ann Arbor, MI) was used to determine the level of protein oxidation 
in gastrocnemius muscle homogenates. All procedures were carried out according to 
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the manufactures guidelines. In brief, ~50mg of gastrocnemius muscle was 
homogenized in ice-cold PBS (pH = 6.7) containing 1mM EDTA and subsequently 
centrifuged for 10,000 x g for 15min at 4°C to obtain a clear supernatant. 400 µL of the 
supernatant was subsequently transferred to two separate tubes, one to be used as a 
background control and one to be used to asses protein carbonyl formation. 2,4-
dinitrophenylhydrazine was added to the sample tube and 2.5 M hydrochloric acid was 
added to each control tube. Both tubes were then incubated in the dark for 1 hour at 
room temperature. Following this incubation 20 % trichloroacetic acid was added to all 
tubes and then briefly placed on ice. The samples were then exposed to a series of 
sequential acid incubations, centrifugations and wash steps as per the manufactures 
directions. After the final wash the pellets were re-suspended in guanidine hydrochloride 
and transferred to the wells of a 96 well plate. The absorbance change was then 
measured at a wavelength of 360nm using a plate reader. Following the readings all 
samples were quantified using a DC protein concentration assay (Bio-Rad, Hercules, 
CA) and the results are presented as nmols of protein carbonyls normalized to the µg of 
protein present in each sample. 
 
Statistics.  Statistical analyses were performed using the SPSS 13.0 software package 
(SPSS, Chicago, IL). An analysis of variance was used to examine differences between 
the three age groups and additionally resveratrol supplementation. Bonferroni post hoc 
analyses were performed between significant means.  A p value < 0.05 was considered 






Descriptive Data. All animals were weighed at the beginning and end of the 
experimental protocol. The data displayed in Table 1 are indicative of the final weight of 
the animals immediately prior to sacrifice. There was no significant difference between 
the body weights of aged control vs. aged resveratrol supplemented animals. Middle-
aged and both aged animal groups were significantly heavier than young animals (34.3 
± 2.3g vs. 34.5 ± 3.9g vs. 26.5 ± 2.1g; p ≤ 0.05). There was no significant effect of 
resveratrol administration on body weight within aged animals. Conversely, both 
gastrocnemius and plantaris muscle wet weights were significantly greater in young 
animals compared to aged and middle-aged animals. The difference was even more 
prominent when muscle wet weights were normalized to their body weights, (Table 1). 
These results are indicative of sarcopenia; however, resveratrol showed no protective 
effect with regard to maintaining muscle mass during aging in either the plantaris, or 
gastrocnemius muscles. 
 
Refer to Table 1 
 
Silent mating type information regulation homolog1, (Sirt1) Enzyme Activity and 
Protein Content. Surprisingly, Sirt1 Activity was significantly  greater  by  25% in 
gastrocnemius muscles from aged animals, compared to their young counterparts. 
Gastrocnemius muscles from resveratrol supplemented animals had a modest, but 
additional increase in Sirt1 activity (2867 ± 108 vs. 3243 ± 107 AFU/µg), (Figure 1A). 
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Sirt1 protein content, as measured by immunoblotting, was similarly greater in muscles 
from aged animals, although to a much larger extent than the activity levels. Muscles 
from aged animals showed, more than a two-fold greater Sirt1 protein content 
compared to muscles from young animals. Resveratrol supplementation did not 
significantly increase Sirt1 protein content in muscles of middle-aged animals, although 
the results approached statistical significance (p= .063), (Figure 1B). 
 
Refer to Figure 1 
 
Peroxisome proliferator-activated receptor gamma coactivator 1 (PGC1) Protein 
Content and Citrate Synthase Enzyme Activity. PGC1 protein content and citrate 
synthase activity were measured as indirect markers of oxidative metabolism and 
mitochondrial content, respectively. PGC1 protein content measured in total 
gastrocnemius muscle homogenate remained unchanged regardless of age, or 
resveratrol supplementation, (Figure 2A). Citrate synthase activity was  ~20% lower in 
muscles from aged animals,  but resveratrol supplementation had no effect on the 
enzyme’s activity (Figure 2B). 
 
Refer to Figure 2 
 
Subcellular Localization of Cytochrome c Protein. Cytochrome c protein content 
was measured, via immunoblotting, in the total, cytosolic (mitochondrial-free), and 
mitochondrial fractions of vastus lateralis muscles as an estimation of both 
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mitochondrial content and mitochondrial membrane permeability. Cytochrome c protein 
content in both the total homogenate and the mitochondrial fractions, remained 
unchanged regardless of age or resveratrol supplementation (Figure 3A). Cytochrome c 
present in the mitochondrial free cytosolic fraction was ~ 10 fold greater in muscles from 
both middle-aged and aged animals regardless of resveratrol supplementation, 
suggesting increased mitochondrial membrane permeability and perhaps an increased 
likelihood of mitochondrial dysfunction present in middle-aged and aged animals (Figure 
3A).  
 
Refer to Figure 3 
 
 
SOD Enzyme Activity and Protein Content. Superoxide dismutase activity was 
measured in vastus lateralis muscles fractioned into mitochondrial and cytosolic 
(mitochondrial-free) fractions. MnSOD activity was assessed in isolated mitochondria 
and CuZnSOD activity was measured in the corresponding mitochondrial free cytosolic 
faction. Total homogenates from the vastus lateralis muscle was used to determine the 
protein content of each SOD isoform. MnSOD activity was similar  in mitochondria 
isolated from vastus lateralis muscles from middle-aged and aged animals relative to 
young muscles. Resveratrol supplementation increased MnSOD activity in muscles 
from aged animals by an additional ~40%, (Figure 4A). There was no aging, or 
supplementation effect on MnSOD protein content (Figure 4B). CuZnSOD activity was 
significantly increased in gastrocnemius muscles from old animals compared to 
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gastrocnemius muscles from young animals (121 ± 6.3 vs. 73.8 ± 6.6 U/ml/mg; p ≤ 
0.05). Resveratrol supplementation significantly decreased CuZnSOD activity in aged 
animals, by 33%, reducing the enzymes activity level to that of young animals (Figure 
4C). There was no change in CuZnSOD protein content with resveratrol 
supplementation, however, aging significantly increased CuZnSOD protein content in 
both middle-aged and aged animals compared to their young counterparts, (Figure 4D). 
 
Refer to Figure 4 
 
Hydrogen Peroxide (H2O2) Concentrations.  H2O2 was assessed in gastrocnemius 
muscle homogenates as an indicator of oxidant load during aging. H2O2 levels were 
~80% higher in gastrocnemius muscles from aged and middle-aged animals when 
compared to gastrocnemius muscles from young animals, (1.88 ± 0.11 vs. 1.80 ± 0.25 
vs. 1.05 ± 0.12 μmols H2O2 /μg protein; p ≤ 0.05).  Resveratrol supplementation 
significantly reduced H2O2 levels in gastrocnemius muscles from aged animals 
compared to gastrocnemius muscles from old control animals, (1.52 ± 0.10 vs. 1.88 ± 
0.11 μmols H2O2 /μg protein; p ≤ 0.05). This reduction represented a 24% decrease in 
H2O2 concentrations, but muscles from aged resveratrol animals still had significantly 
higher levels of  H2O2 when compared to young muscles (Figure 5A). 
 
Lipid Peroxidation. Malondialdehyde (MDA) and 4-hydroxyalkenals (HAE) were 
assessed in whole muscle homogenates as indicators of oxidative damage, specifically 
as markers of muscle lipid peroxidation. Lipid peroxidation was increased in aged 
111 
 
animals compare to their young counterparts (0.251 ± 0.04 vs. 0.442 ± 0.05 µM 
[MDA/HAE]/mg protein; p ≤ 0.05). Muscles from middle-aged animals did not show 
elevated markers of lipid peroxidation when compared to muscles from young animals. 
Resveratrol supplementation was able to partially attenuate the increase in lipid 
peroxidation that occurred due to aging. Gastrocnemius muscles from aged 
supplemented animals had a 20% reduction in MDA and HAE levels compared to aged 
control animals (0.354 ± 0.02 vs. 0.442 ± .05 µM [MDA/HAE]/mg protein; p ≤ 0.05), 
(Figure 5B). 
 
Protein Oxidation.  Protein carbonyl formation was measured in gastrocnemius muscle 
homogenates as an indicator of protein oxidation caused by oxidative stress. Muscles 
from both aged and middle-aged animals showed significantly greater concentrations of 
protein carbonyl formation compared to muscles from their young counter parts (7.43 ± 
1.3 vs. 7.10 ± 1.2 vs. 4.63 ± .67 nmol/ml/µg; p ≤ 0.05). Resveratrol supplementation was 
unable to mitigate protein oxidation in aged animals as measured by carbonyl formation  
(Figure 5C). 
 
Refer to Figure 5 
 
Ex Vitro Physiological Analyses. Isometric muscle contractile properties were 
examined in the plantaris muscles of control and resveratrol-treated mice (Figure 6). 
The force frequency curve was shifted significantly rightward in resveratrol 
supplemented aged mice, compared to aged control mice (Figure 6A). This rightward 
112 
 
shift is indicative of a faster muscle profile. These results were completely unexpected 
given that previous literature has shown that dietary resveratrol supplementation 
improves muscular endurance (40) and increases mitochondrial biogenesis in skeletal 
muscle (6; 40) which would likely shift the force frequency curve leftward to represent a 
slower muscle profile. Additionally, CT and ½ RT were analyzed to determine if 
resveratrol had any effect on the twitch properties of plantaris muscles, (Figure 6B). 
Plantaris muscles from middle-aged animals had a significantly shorter contraction 
times than did muscles from aged control animals, (32.8 ± 2.1 ms vs. 39.6 ± 1.4 ms; p ≤ 
0.05). Similarly, muscles from resveratrol supplemented animals also showed shortened 
contraction times compared to aged control animals (34.7 ± 0.8 ms vs. 39.6 ± 1.4 ms; p 
≤ 0.05), eliminating any aging effect between middle-aged and aged resveratrol 
supplemented animals. These data are consistent with the rightward shift in the force 
frequency curve of muscles from resveratrol supplemented animals (Figure 6.A). No 
differences were found in the ½ RT (Figure 6.B), or the twitch to tetanus ratio (Pt/Po) of 
plantaris muscles with respect to age or resveratrol supplementation, (Figure 6C). 
Lastly, a modified Burke protocol (10) was implemented to assess muscle fatigue in 
plantaris muscles. The fatigue protocol consisted of 3 minutes of 120 electrically evoked 
contractions at 40 Hz. Each contraction was for 1.0s with a 33.3% duty cycle. The pulse 
duration was 200 µs. There was no difference between the fatigue index of middle-aged 
and aged control animals and furthermore, resveratrol was unable to improve fatigue 
resistance in plantaris muscles (Figure 6D).   
 





Oxidative stress is believed to be a common underlying mechanism potentiating 
many of the factors leading to muscle loss with aging (22; 56). There appears to be 
inherent alterations in the endogenous antioxidant defense systems that occur with 
aging in skeletal muscle (54; 58). Although there is an incongruence in the literature as 
to whether antioxidant enzyme activities increase, or decrease, with aging; there is an 
abundance of evidence suggesting that the antioxidant defense system in aged 
individuals can be more easily overwhelmed by oxidants leading to oxidative stress and 
consequent oxidative damage (53; 65; 72). Increased oxidant production and/or an 
attenuated capacity to buffer oxidants may result in reductions in muscle function due to 
both muscle atrophy and also functional decrements that go beyond the linear 
relationship between muscle cross-sectional area and force generation (16; 31; 61). 
Given that the definition of sarcopenia is the loss of muscle mass and function with 
aging, (64) it stands to reason that there may be a possible link between increases in 
oxidative stress with aging and the progression of sarcopenia.  
The source of increased ROS present in aged skeletal muscle most likely 
originates in the mitochondria. Age-related mitochondrial alterations underlie a wide 
variety of diseases such as diabetes (45), neurodegeneration (70) and sarcopenia (13). 
The premise behind this relationship is based on the theory that with advanced age 
there are more dysfunctional mitochondria present within a cell (44). These defective 
mitochondria contain “leaky” electron transport chains and thus more oxidants are 
produced leading to oxidative stress (13; 28). The process is cyclic; with more 
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mitochondrial uncoupling, there are more pro-oxidants present to further damage 
vulnerable membrane phospholipids (28; 53). Consequently mitochondrial derived 
superoxide generation increases with advanced age (50).  
 Supplementation with the naturally occurring polyphenol, resveratrol, has the 
potential to alleviate oxidative stress in aged skeletal muscle via activation of Sirt1, by 
favorably augmenting endogenous anti-oxidant enzymes (27; 39) and enhancing 
mitochondrial function (40) and biogenesis (6). The present study sought to determine 
the efficacy of long-term resveratrol supplementation to alleviate oxidative stress from 
middle-age through senescence and to attenuate the progression of sarcopenia. 
 As expected, sarcopenia was present in both plantaris and gastrocnemius 
muscles from aged animals (Table1). Interestingly, although muscles from middle-aged 
animals were also significantly heavier than muscles from aged animals, when 
normalized to bodyweight, muscles from middle-aged animals already showed a relative 
decrease in muscle mass when compared to muscles from young animals. Counter to 
our hypothesis, resveratrol supplementation was not able to attenuate the loss of 
muscle mass or relative muscle mass in aged animals, nor did dietary resveratrol 
supplementation affect animal body weight (Table1). 
Resveratrol supplementation moderately, but significantly, enhanced Sirt1 activity   
(Figure 1A) in gastrocnemius muscles from aged animals compared to muscles from 
animals on the control diet. There was a tendency for Sirt1 protein levels to be elevated 
by dietary resveratrol supplementation, however, these results did not reach statistical 
significance (p=0.063) (Figure 1B) and this is congruent with literature showing that 
supplementation with resveratrol primarily acts via increasing Sirt1 activation, not 
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protein content (6). Somewhat unexpectedly, both Sirt1 activity and protein levels 
increased with aging (Figure 1A-B). We had originally theorized that Sirt1 activity would 
be decreased in aged animals in light of the fact that upregulation of Sirt1, with 
resveratrol, can protect against certain facets of aging (5; 55). However, Sirt1 has 
recently been found to be upregulated in heart muscle in response to both exogenous 
stress and aging (1), suggesting that Sirt1 is elevated in muscles of aged animal and 
likely represents an attempt to confer protection against endogenous and exogenous 
stressors. These results are in agreement the findings of the current study. 
Nevertheless, this elevation in Sirt1 protein and activity was insufficient to protect 
skeletal muscle against sarcopenia. 
Sirt1 is a known positive regulator of PGC1 (63) and as such has the potential to 
influence pathways involved in mitochondrial biogenesis and oxidative metabolism. 
Long-term resveratrol supplementation did not increase total PGC1 protein content in 
aged gastrocnemius muscles, nor did total PGC1 protein content change with aging 
(Figure 2 A). Given that total PGC1 protein levels may not be sensitive to changes in 
the actual functional capacity of PGC1, the enzymatic activity of citrate synthase was 
also analyzed as a marker of oxidative metabolism and mitochondrial content. Citrate 
synthase activity was similarly unaffected by resveratrol supplementation, however, 
citrate synthase activity was sensitive to age-related alterations and was significantly 
decreased in aged animals, (Figure 2B). Congruent with the results of the citrate 
synthase assay, cytochrome c release from the mitochondria was increased in muscles 
from aged and middle-aged animals, but was not ameliorated with resveratrol 
supplementation, (Figure 3A). It should be noted that in the current investigation the 
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subcellular localization of cytochrome c was used as an indicator of mitochondrial 
membrane integrity and content, although traditionally cytochrome c release is used as 
a hallmark of apoptosis (1) . Taken as a whole, these data seem to indicate that 
although Sirt1 activity was enhanced with resveratrol supplementation, it was not 
increased enough to enhance PGC1 signaling and thus had no measurable influence 
on mitochondrial membrane integrity, mass, or metabolism. 
Long-term resveratrol supplementation was successful at mediating endogenous 
antioxidant enzymes and markers of oxidative stress and oxidative damage in muscles 
from aged animals. Specifically, resveratrol administration significantly increased 
MnSOD activity, while having an opposing effect on CuZnSOD activity by significantly 
decreasing it in vastus lateralis muscles, (Figure 4A & C). On the other hand, resveratrol 
supplementation did not alter either SOD isoform at the protein level (Figure 4 B & D).  
The ability of resveratrol to induce MnSOD is commonly accepted and it is believed that 
resveratrol augments Sirt1 activity which in turn upregulates MnSOD in a FOXO3a 
dependent manner (77). Acute resveratrol supplementation has previously been shown 
to enhance MnSOD at both a gene (67) and protein (32) level in addition to enhancing 
the enzyme’s activity, suggesting that there may be differential signaling with regard to 
MnSOD regulation between acute and chronic exposure to resveratrol. CuZnSOD 
activity is known to be increased with aging and in other conditions eliciting elevated 
levels of oxidative stress (35), so it seems plausible that resveratrol’s ability to reduce 
the muscle’s oxidant load by reducing of H2O2 concentrations (Figure 5 A) may have 
prevented the aging-induced increase in CuZnSOD activity, resulting in a younger 
antioxidant profile.  
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The reduction of H2O2 concentrations in gastrocnemius muscles from aged 
animals supplemented with resveratrol appears to have assuaged the accumulation of 
the lipid peroxidation byproducts Malondialdehyde (MDA) and 4-hydroxyalkenals (HAE). 
This is consistent with recent data from our laboratory and others that have shown that 
resveratrol protects against H2O2  mitigated lipid peroxidation in vivo (32; 67) and in vitro 
(9). Although the muscle oxidant load (H2O2) was reduced and the level of lipid 
peroxidation was attenuated in aged gastrocnemius muscles, resveratrol 
supplementation was unable to protect skeletal muscle from aging-induced protein 
oxidation as measured by protein carbonyl formation (Figure 5C). This observation 
differs from recent rodent studies in both diabetic (52) and cancer (8) models showing 
that resveratrol was able to diminish protein oxidation in vivo. It is probable that the 
results of the current study are more representative of the effects that resveratrol can 
have under basal conditions in aged animals and it may prove to be more protective 
under perturbations that involve excessive stress such as disease states and/or injuries 
resulting in chronic inflammation, or under muscle wasting conditions such as cachexia 
or hindlimb suspension.  
Given that resveratrol supplementation has been shown to improve muscular 
endurance (40) and increase mitochondrial biogenesis in skeletal muscle (6; 40), it was 
conjectured that the primarily fast twitch plantaris muscles from supplemented animals 
would show an  improved resistance to fatigue. Presumably these muscles would show 
a shift in muscle characteristics that would be more in line with a slower muscle 
phenotype. This did not turn out to be the case, and in fact, resveratrol supplementation 
not only conferred no protection against muscle fatigue (Figure 6D), it in fact shifted the 
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force-frequency curves of the plantaris muscles rightward (Figure 6A), indicating that 
the muscles had properties more consistent with a faster phenotype. One possible 
explanation for this phenomenon is that resveratrol supplementation, by retarding 
oxidative stress and damage, may have prevented the atrophy and/or loss of type II 
fibers that is known to occur in aged skeletal muscle (42) and thus was able to preserve 
a younger muscle profile. It is also possible, although not addressed in the current 
study, that resveratrol could improve the capacity of aged muscles to regenerate. In a 
recent study, resveratrol stimulated muscle precursor cell proliferation in a Sirt1- 
dependent manner (60), further expanding the mechanisms by which resveratrol 
supplementation may improve muscle mass and function by enhancing muscles 
regenerative capacity, which has been shown to be augmented with aging (17; 18) and 
in certain pathological conditions.  
Taken as a whole, the results of the current study indicate that long-term dietary 
supplementation with moderate doses of resveratrol may prove to be beneficial by 
upregulating MnSOD and thus reducing the oxidant load present in the skeletal muscle 
environment and hence preventing some measures of oxidative damage. However, the 
current experimental protocol proved to be insufficient to enhance mitochondrial 
integrity or content. It is possible that a greater increase in Sirt1 protein and/or activity 
may be needed before a change in mitochondrial function will be observed. Further 
work is needed to determine if resveratrol has the potential to be an effective 
therapeutic agent to treat muscle functional decrements associated with elevated 
oxidative stress in aged individuals or in conditions of muscle loss such as prolonged 
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bedrest, presumably through a pharmacological pre-conditioning effect resulting in an 
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Table 1 Descriptive Data. Animals were weighed prior to sacrifice, body weights 
(BW) are represented in grams (g). Gastrocnemius and plantaris muscles 
were dissected, immediately blotted and weighed as an estimate of 
muscle size. The data are presented in grams (g), or as a ratio to the 
animal’s body weight (mg/g). Food consumption was assessed for each 
experimental group and is reported as g of food per day. Resveratrol was 
fed to aged mice for 10 months in a rodent chow that contained 0.05% 
trans-resveratrol. Resveratrol intake is reported as grams per day 
normalized to kg of bodyweight (g/kg/day). Significance was set at (p ≤ 
0.05) and all data are represented as mean ± standard error.  # denotes 






Figure 1  Silent mating type information regulation homolog1 (Sirt1) enzyme 
activity and protein content. (A) Sirt1 protein content was measured via 
immunoblotting in total gastrocnemius muscle homogenate (B) Sirt1 
enzyme activity was determined fluorometrically in gastrocnemius muscle 
homogenate. Data are expressed as arbitrary fluorescent units (AFU)/µg 
protein. YC= Young Control, MAC = Middle-Aged Control, AC = Aged 
Control, AR = Aged Resveratrol. Significance was set at (p ≤ 0.05) and 
all data are presented as mean ± standard error. # p ≤ 0.05, young control 
(Aging Effect). * p ≤ 0.05, aged control vs. age resveratrol 
(Supplementation Effect). 
 
Figure 2 PGC1 protein content and citrate synthase enzyme activity (A) PGC1 
protein content was measured via immunoblotting in gastrocnemius 
muscle homogenate (B) Citrate synthase enzyme activity was measured 
kinetically in homogenates from gastrocnemius muscles. Data are 
expressed as µmol/min/mg protein. YC= Young Control, MAC = Middle-
Aged Control, AC = Aged Control, AR = Aged Resveratrol. 
Significance was set at (p ≤ 0.05) and all data are represented as mean ± 
standard error. # p ≤ 0.05, young control (Aging Effect). * p ≤ 0.05, aged 




Figure 3 Subcellular cytochrome c protein content. (A) Cytochrome c protein 
content was measured, via immunoblotting, in the total, cytosolic 
(mitochondrial-free), and mitochondrial fractions of vastus lateralis 
muscles as an estimation of both mitochondrial content and mitochondrial 
membrane integrity. (B) Immunoblots of the mitochondrial form of SOD 
(MnSOD) and the cytosolic form of SOD (CuZnSOD) to illustrate the purity 
of the tissue fractions. YC= Young Control, MAC = Middle-Aged 
Control, AC = Aged Control, AR = Aged Resveratrol.  Significance was 
set at (p ≤ 0.05) and all data are represented as mean ± standard error.  # 
p ≤ 0.05, young control (Aging Effect). * p ≤ 0.05, aged control vs. age 
resveratrol (Supplementation Effect). 
 
 
Figure 4   Isoform specific superoxide dismutase activity and protein content. 
(A) MnSOD activity was assessed colorimetrically in mitochondria isolated 
from vastus lateralis muscles. Data are expressed as U/mL/mg protein. 
(B) MnSOD protein content was analyzed via immunoblotting in isolated 
mitochondria of vastus lateralis muscles (C) CuZnSOD activity was 
assessed colorimetrically in the mitochondria-free cytosolic fraction from 
vastus lateralis muscles. Data are expressed as U/mL/mg protein.  (D) 
CuZnSOD protein content was analyzed via immunoblotting in the 
mitochondria-free cytosolic fraction of vastus lateralis muscles. YC= 
Young Control, MAC = Middle-Aged Control, AC = Aged Control, AR 
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= Aged Resveratrol. Significance was set at (p ≤ 0.05) and all data are 
represented as mean ± standard error. Significance was set at (p ≤ 0.05) 
and all data are represented as mean ± standard error. # p ≤ 0.05, young 
control (Aging Effect). * p ≤ 0.05, aged control vs. age resveratrol 
(Supplementation Effect). 
 
Figure 5 Resveratrol attenuated increases in hydrogen peroxide (H2O2) 
concentration and lipid peroxidation associated with aging, but did 
not prevent protein carbonyl formation.  (A) H2O2 concentrations were 
determined fluorometrically in gastrocnemius muscle homogenate. Data 
are expressed as µmols/H2O2/µg protein. Significance was set at (p ≤ 
0.05) and all data are represented as mean ± standard error. (B) MDA & 
HAE levels were evaluated as a combined marker of lipid peroxidation and 
expressed in µM[MDA/HAE]/mg protein. (C) Protein carbonyl formation 
was analyzed as a marker of protein oxidation in gastrocnemius muscle 
homogenate. Data are expressed as nmol/mL.  YC= Young Control, 
MAC = Middle-Aged Control, AC = Aged Control, AR = Aged 
Resveratrol. Significance was set at (p ≤ 0.05) and all data are 
represented as mean ± standard error.   # p ≤ 0.05, young control (Aging 





Figure 6 In vitro muscle physiological analyses. Isometric muscle contractile 
properties were examined in the plantaris muscles of control and 
resveratrol-treated mice. (A) Graphical depiction of a force frequency 
curve illustrating the maximal force produced in plantaris muscles at a 
given frequency. Data are presented as the force production at a given 
stimulation frequency relative to maximal force of that muscle. (B) 
Contraction time  (CT)and ½ relaxation time (½ RT) were analyzed to 
determine twitch properties in plantaris muscles. Data are presented as a 
unit of time (ms) (C) The twitch to tetanus ratio (Pt/Po) was assessed in 
plantaris muscles. Data are presented as a ratio of twitch force to maximal 
force.(D) A modified Burke protocol was implemented to asses muscle 
fatigue in plantaris muscles. Data are presented as a measure of fatigue 
index, calculated as a percent change from the first to last contraction 
(120th). MAC = Middle-Aged Control, AC = Aged Control, AR = Aged 
Resveratrol.  Significance was set at (p ≤ 0.05) and all data are 
represented as mean ± standard error. * p ≤ 0.05, aged control vs. age 
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Chapter 4: General Discussion and Conclusions: 
 
Overview:   
 The overall goal of this dissertation was to determine the efficacy of resveratrol 
supplementation to ameliorate the detrimental relationship between oxidative stress, 
apoptosis and skeletal muscle atrophy as they pertain to both muscle disuse and aging.  
Furthermore, the included studies sought to elucidate resveratrol’s capacity to 
upregulate silent mating type information regulation homolog1, (Sirt1), and to determine 
if upregulation of Sirt1 by resveratrol would enhance mitochondrial integrity and content. 
Our long-term goal was to determine if supplementation with resveratrol could prove to 
be an effective therapeutic agent to attenuate muscle atrophy associated with chronic 
disuse (hypodynemia and hypokinesia) and also to ascertain if long-term 
supplementation with dietary resveratrol could prove to be an effective countermeasure 
to slow the progression of sarcopenia, the age-associated loss of muscle mass and 
function.  
The central hypothesis of the dissertation was that resveratrol would protect 
skeletal muscle from oxidative stress via upregulation of the endogenous antioxidant 
system and augmentation of mitochondrial membrane integrity. This would result in a 
reduction of both oxidant release and pro-apoptotic protein release from the 
mitochondria, the leading to reduction in oxidative damage and downstream apoptosis, 
with the expected outcome to be an attenuation of muscle atrophy. The rational for the 
project was to shed light on molecular mechanisms of muscle atrophy induced by both 
aging and disuse and to attempt to a possible intervention, via resveratrol 
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supplementation, to help limit increased oxidant exposure and thus an atrophic muscle 
environment.  
Taken as a whole the cumulative results of the dissertation are in agreement with 
the majority of the current literature confirming that increases in oxidative stress occur 
concomitantly with both disuse-mediated skeletal muscle atrophy (chapter 2) and 
sarcopenia (chapter 3). Furthermore, apoptotic signaling in the skeletal muscle 
environment was increased in response to both hindlimb suspension and advanced age 
(chapter 2). The novelty of this dissertation was to evaluate the efficacy of resveratrol 
supplementation to attenuate oxidative stress and thus mitigate downstream mediators 
of muscle atrophy.  
The efficacy of resveratrol to mitigate the effects of skeletal muscle disuse: 
Hindlimb suspension (HLS), which is a model that elicits both hypodynemia and 
hypokinesia in conjunction with unloading of the hindlimb muscles, caused significant 
atrophy of gastrocnemius muscles from both young and aged animals (Figure 2.5). 
Oxidative stress and apoptotic signaling were also elevated in response to HLS in 
muscles from both young and aged animals, although to a greater extent in muscles 
from aged animals. This study yielded mixed results with regard to the efficacy of 
resveratrol administration to ameliorate disuse mediated atrophy. With the exception of 
the upregulation of catalase activity (Figure 2.4) in muscles from young HLS animals, 
resveratrol had no protective, or detrimental, effects on muscles from young animals. In 
aged gastrocnemius muscles, twenty-one days of resveratrol administration was 
effective at reducing both hydrogen peroxide (H2O2)  
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concentrations and oxidative damage in the form of lipid peroxidation (Figure 2.3) in 
muscles exposed to HLS. These reductions in oxidative stress indices coincided with 
the fact that resveratrol enhanced the endogenous anti-oxidant system in the form of 
increases in both MnSOD and catalase protein contents and enzymatic activities 
(Figure 2.2). Although not addressed in chapter 2, increases in MnSOD and catalase 
activity were likely mediated by resveratrols ability to upregulate Sirt1 in gastrocnemius 
muscles from aged animals (Figure 4.1), given that resveratrol has been repeatedly 
shown to upregulate endogenous antioxidant enzymes in a Sirt1-FOXO dependent 
manner (as discussed in Chapter 1).  
 
Figure 4.1- Sirtuin 1 protein content in gastrocnemius muscles. Gastrocnemius muscles from young and 
aged animals exposed to 21 days of resveratrol administration (12.5mg/kg/day) and 14 days of hindlimb suspension. 
YC= Young Control, YS = Young Suspended, OC = Old Control, OS = Old Suspended, YVC = Young Vehicle 
Control, YVCS = Young Vehicle Control Suspended, YRC = Young Resveratrol Control, YRS = Young 
Resveratrol Suspended, OVC = Old Vehicle Control, OVCS = Old Vehicle Control Suspended, ORC = Old 
Resveratrol Control, ORS = Old Resveratrol Suspended. **p ≤ 0.05, non-suspended control vs. suspended 
animals (Suspension effect). # p ≤ 0.05, old vs. young treatment matched (Aging effect). *p ≤ 0.05, vehicle control vs.  
age-matched and treatment matched groups (Effect of resveratrol). 
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Despite reductions in pro-apoptotic signaling and the upregulation of the anti-
apoptotic protein Bcl-2 (Figure 2.5), resveratrol administration was not an effective 
countermeasure to disuse-mediated increases in apoptotic signaling in aged skeletal 
muscle. However, in terms of the functional outcomes the results were quite promising. 
Resveratrol administration was effective in preserving the relative ratio of muscle mass 
to body mass and significantly attenuated the loss of maximal isometric force in aged 
plantarflexor muscles following HLS (Figure 2.5). Similarly to both, indices of oxidative 
stress and apoptosis this protective effect of resveratrol was age dependent and only 
present in aged animals. To the author’s knowledge this is the first study presenting 
data that shows a clear differential effect of resveratrol in skeletal muscle that is 
dependent upon the age of the animal. The overall results of the study indicate that 
resveratrol has the potential to be a therapeutic agent, likely through a pharmacological 
pre-conditioning effect that acts to upregulate the endogenous anti-oxidant enzyme 
system potentiating the system to be able to handle the increased oxidant load that is 
present in acute conditions of muscle wasting.  
Sarcopenia progression in long-term resveratrol supplemented animals.  
Given the fact that acute resveratrol supplementation was effective at reducing 
oxidative stress and preserving relative muscle mass and function in aged skeletal 
muscle following disuse-mediated atrophy, the second study in this dissertation sought 
to ascertain if long-term dietary supplementation with resveratrol would reduce the 
chronic basal levels of oxidative stress that are often found in aged skeletal muscle. My 
hopes were that by reducing oxidative stress over a long period of time, resveratrol 
could potentially slow the progression of sarcopenia. Additionally, in light of the fact that 
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resveratrol was able to upregulate Sirt1 following acute administration (figure 4.1), the 
second study aimed to clarify if upregulation of Sirt1 by resveratrol over prolonged 
periods would affect mitochondrial signaling, as measured by PGC1 signaling which is a 
known target of Sirt1 (as discussed in chapter 1) 
 Muscles from aged (28mo) mice weighed significantly less than muscles from 
either young (6mo), or middle-aged mice (18mo), even when normalized to body weight 
confirming the notion that with advanced age there is a progressive loss of muscle mass 
(Figure 3.1).  Counter to what was hypothesized, long-term (10mo) dietary 
supplementation with resveratrol was unable to attenuate sarcopenia in either 
gastrocnemius or plantaris muscles (Table 3.1). Despite the lack of preservation of 
muscle mass seen in supplemented animals, dietary resveratrol supplementation was 
effective in reducing indices of oxidative stress including reduction of H2O2 levels and 
lipid peroxidation levels (Figure 3.4). In congruence with the effects of resveratrol on 
aged muscle from HLS animals, long-term resveratrol supplementation effectively 
upregulated MnSOD activity and decreased CuZnSOD activity. Presumably these 
results are due to the interplay of increased MnSOD activity effectively reducing H2O2 
concentrations and in turn the reduction in H2O2 levels are likely responsible for the 
reductions in CuZnSOD activity which is known to become upregulated in response to 
oxidant load.  
 Although not addressed in the main body of chapter two, markers of apoptotic 
signaling and DNA fragmentation were assessed in vastus lateralis muscles to 
determine if reductions in oxidative stress would results in a reduction in the 
translocation of the pro-apoptotic Bax to the mitochondrial membrane. As discussed at 
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length in chapter 1, this translocation is initiated by an oxidant-sensitive conformational 
change in the Bax protein that allows Bax to disassociate from the anti-apoptotic protein 
Bcl-2 in the cytoplasm. This leaves Bax free to translocate to the outer-mitochondrial 
membrane and initiate pore formation leading to an eventual loss of mitochondrial 
membrane integrity, the end result being a release of cytochrome c and eventual 
apoptosis. Long-term resveratrol supplementation was not effective in reducing the 
translocation of Bax to the mitochondria, nor was it effective in reducing the total 
cytosolic protein content of Bax (Figure 4.2). Moreover, unlike the results from the acute 
administration of resveratrol, long-term supplementation with resveratrol was unable to 
increase the anti-apoptotic Bcl-2 protein (Figure 4.2) or lower caspase 3 activity (Figure 
4.3).  
 
Figure 4.2- The subcellular localization of Bax and Bcl-2. Vastus lateralis muscles were fractionated into a 
mitochondrial pellet and a mitochondria-free cytosolic fraction for assessment of the subcellular localization of the 
pro-apoptotic Bax protein and the anti-apoptotic Bcl-2 protein. A. Immunblot analysis of Bax protein content. Data are 
expressed as a measure of optical density and a representative ponceau stain is displayed as qualitative assurance 
of equal protein loading. B. Immunblot analysis of Bcl-2 protein content. Data are expressed as a measure of optical 
density and a representative ponceau stain is displayed as qualitative assurance of equal protein loading. YC = 
152 
 
young control, MAC = middle-aged control AC = aged control AR = aged resveratrol supplemented. 
Significance was set at (p ≤ 0.05) and all data are presented as mean ± standard error. # p ≤ 0.05, young control 
(Aging Effect).  
 
Figure 4.3- Apoptotic Signaling:  Apoptotic indices were measured in vastus lateralis muscles. A. A fluorescent 
enzyme activity assay was used to assess the activity of the executioner caspase, caspase 3, within vastus lateralis 
muscle homogenate. The data are presented as normalized fluorescent intensity. B. An ELISA quantifying DNA 
fragmentation was implemented to estimate the levels of apoptosis, within vastus lateralis muscles. The results are 
represented as normalized optical density readings and are linearly related to the amount of fragmented DNA present 
in the muscle homogenate. YC = young control, MAC = middle-aged control AC = aged control AR = aged 
resveratrol supplemented. Significance was set at (p ≤ 0.05) and all data are presented as mean ± standard error. 
# p ≤ 0.05, young control (Aging Effect).  
 
Not surprisingly then, there was no attenuation of DNA fragmentation (Figure 
4.3), the hallmark of apoptosis, by long-term resveratrol supplementation. These data 
highlight the differences between acute and long-term exposure to resveratrol and also 
suggest that a perturbation may be necessary (i.e. muscle disuse) in order to observe 
any protective effective that is attributable to resveratrol supplementation. Furthermore, 
the results of the dissertation as whole bring into question the assumed linear 
relationship that is often thought to exist between oxidative stress and apoptosis. It 
seems more likely that the increases in oxidative stress and apoptotic signaling that 
occur with both advanced age and muscle wasting conditions are concomitant 
conditions that although may be correlated are not casual to each other. 
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Sirt1 activity was modestly upregulated following ten months of dietary 
resveratrol supplementation (Figure 3.1). Unfortunately, this augmented Sirt1 activity did 
not translate to increased citrate synthase activity, PGC1 protein content or improved 
mitochondrial membrane integrity. It was hypothesized that through the upregulation of 
Sirt1 and subsequently PGC1, skeletal muscles from supplemented animals would 
display enhanced resistance to muscle fatigue. This hypothesis was rejected since 
plantaris muscles from aged supplemented animals did not show any resistance to 
muscle fatigue (figure 3.6), it should be noted that muscle fatigue was measured ex vivo 
and therefore these data were unable to take into account neuronal, and/or systemic 
factors that can contribute to muscle fatigue. Furthermore, plantaris muscles from 
supplemented animals displayed a rightward shift of their force-frequency curves 
indicative of a faster muscle profile, a direct contrast to what one would expect from a 
muscle that had undergone a metabolic shift to a more oxidative state.  
Although others have shown that resveratrol’s ability to activate Sirt1 leads to a 
PGC1-mediated enhancement of oxidative metabolism, muscle fatigue resistance and 
mitochondrial biogenesis, our results do not corroborate a relationship between Sirt1 
upregulation and PGC1 signaling. This may be due in part to the wide range of 
dosages, treatment durations and modalities of resveratrol administration present in the 
current body of literature.  The results of this dissertation suggest that the capacity of 
resveratrol to protect skeletal muscle from increases in oxidative stress and 
consequently oxidative damage likely resides in resveratrols ability to activate Sirt1 and 
via this upregulation enhance components of the endogenous anti-oxidant system. It 
also would seem that increases in oxidative stress can influence muscle mass and 
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function, but they are not causative factors mediating apoptosis in skeletal muscle. It is 
also possible, given that resveratrol has been shown to be an effective anti-
inflammatory agent, that reductions in inflammation within aged skeletal muscle lessen 
the effects of exogenous stressors and therefore improve the outcomes of muscle 
following atrophy-mediating events. Further work is needed to determine if resveratrol 
has the potential to be an effective therapeutic agent to treat muscle functional 
decrements associated with chronic elevated oxidative stress in aged individuals. 
However, its effectiveness as a pharmacological pre-conditioner in response to acute 
stress seems to be better established and appears to be the result of improving the 
redox status associated with atrophic conditions. 
 
Future directions and recommendations: 
Upcoming studies that seek to further understand of the molecular effects of 
resveratrol on skeletal muscle may be better served to focus on pathways outside of the 
oxidative stress-apoptosis continuum and perhaps investigate in more detail the Sirt1- 
dependent effects that resveratrol can have on stress resistance (i.e. FOXO mediated 
upregulation of MnSOD and Catalase) and mitochondrial signaling. Furthermore, given 
the relative importance of insulin like growth factor (IGF-1) and mammalian target of 
rapamycin (mTOR) signaling with regard to muscle protein synthesis it would also be 
interesting and prudent to evaluate the effects, if any, that resveratrol and Sirt1 signaling 
may have with regard to this metabolic signaling network, given that Sirt1 is a powerful 
modulator of many metabolic pathways including insulin signaling. Although the current 
experimental protocol did not elicit enhanced PGC1 signaling, this is likely due to the 
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dosage and modality of supplementation. Other investigators have shown successful 
augmentation of mitochondrial biogenesis and improved oxidative capacity in skeletal 
muscle from rodents receiving dietary resveratrol supplementation that was prepared in 
a high fat medium. Given that resveratrol, is fat soluble, the lack of increased fat content 
in our dietary model may have prevented maximal absorption of the compound and 
could explain the failure of resveratrol to bring about an increase in PGC1 signaling in 
the current study. Therefore if the chosen route of resveratrol exposure is going to be 
dietary, the chow should be made with a higher fat content. 
To better determine if resveratrol protects against increased oxidative stress by 
both augmenting the antioxidant defense system and enhancing mitochondrial 
biogenesis, more exact measures to quantify mitochondrial function and content should 
be used. Fluorescent activated cell sorting analysis could be employed to more directly 
measure mitochondrial density, size and internal  complexity,  electron transport chain 
respiratory capacity to quantify mitochondrial capacity  and mitochondrial membrane 
potential (ΔΨm)  could be measured by flow cytometry using the ratiometric dye 
5,5’,6,6’-tetrachloro-1,1’,3,3’ tetraethylbenzimidazol carbocyanine iodide (JC-1; 
Molecular Probes, Carlsbad, CA). Additionally, pinpointing the source of ROS from the 
mitochondria could be obtained concomitantly to mitochondrial respiratory 
measurements by using the oxidation-dependent compound, dihydroethidium, to 
measure intracellular levels of O2●– and ROS in isolated mitochondria by flow cytometry. 
With regard to skeletal muscle form and function it would be both novel and beneficial to 
measure the effects of resveratrol on muscle fiber composition and cross-sectional 
area. To date the literature has only established the effects of resveratrol 
156 
 
supplementation on skeletal muscle enzyme composition and muscle wet weight.  
There are also several Sirt1 transgenic models to choose from that may prove to be 
more exact in delineating the exact molecular signaling pathways that Sirt1 targets and 
thus further the understanding of the potential therapeutic role(s) that resveratrol may 
fulfill.  
 Janna R. Jackson       
125 Cobblestone Circle, Morgantown, WV  26505 
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